JP2002020362A - New biphenyl derivative - Google Patents
New biphenyl derivativeInfo
- Publication number
- JP2002020362A JP2002020362A JP2000245314A JP2000245314A JP2002020362A JP 2002020362 A JP2002020362 A JP 2002020362A JP 2000245314 A JP2000245314 A JP 2000245314A JP 2000245314 A JP2000245314 A JP 2000245314A JP 2002020362 A JP2002020362 A JP 2002020362A
- Authority
- JP
- Japan
- Prior art keywords
- ethyl acetate
- solution
- biphenyl
- stirred
- hydroxybiphenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical class C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 title claims abstract description 12
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 11
- 150000001875 compounds Chemical class 0.000 claims description 32
- 125000001424 substituent group Chemical group 0.000 claims description 6
- 125000006491 4-t-butyl benzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])*)C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 2
- 229940123142 Steroid sulfatase inhibitor Drugs 0.000 abstract description 6
- 201000010099 disease Diseases 0.000 abstract description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 4
- DNXHEGUUPJUMQT-UHFFFAOYSA-N (+)-estrone Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 DNXHEGUUPJUMQT-UHFFFAOYSA-N 0.000 abstract description 3
- 206010006187 Breast cancer Diseases 0.000 abstract description 3
- 208000026310 Breast neoplasm Diseases 0.000 abstract description 3
- 206010014733 Endometrial cancer Diseases 0.000 abstract description 3
- 206010014759 Endometrial neoplasm Diseases 0.000 abstract description 3
- 201000009273 Endometriosis Diseases 0.000 abstract description 3
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 abstract description 3
- 206010046798 Uterine leiomyoma Diseases 0.000 abstract description 3
- 229960003399 estrone Drugs 0.000 abstract description 3
- 101150047265 COR2 gene Proteins 0.000 abstract 1
- 101100467189 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) QCR2 gene Proteins 0.000 abstract 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 249
- 239000000243 solution Substances 0.000 description 90
- -1 4'-acetylbiphenyl-4-yl sulfamate 4 '-[2- (4-t-butylphenyl) -acetyl] -Biphenyl-4-ylsulfamate 4 '-(n-pentanoyl) -biphenyl-4-yl Sulfamate 4 '-(n-heptanoyl) -biphenyl-4-yl Sulfamate Chemical compound 0.000 description 62
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 60
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 51
- 239000013078 crystal Substances 0.000 description 46
- 239000011541 reaction mixture Substances 0.000 description 44
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 40
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 34
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 32
- 239000000203 mixture Substances 0.000 description 32
- 229910052739 hydrogen Inorganic materials 0.000 description 29
- 239000005457 ice water Substances 0.000 description 27
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 23
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 22
- 238000000921 elemental analysis Methods 0.000 description 21
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 18
- 238000001035 drying Methods 0.000 description 17
- 229960001701 chloroform Drugs 0.000 description 16
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
- 239000012046 mixed solvent Substances 0.000 description 15
- 238000004440 column chromatography Methods 0.000 description 14
- JTGCXYYDAVPSFD-UHFFFAOYSA-N 4-(4-hydroxyphenyl)benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C1=CC=C(O)C=C1 JTGCXYYDAVPSFD-UHFFFAOYSA-N 0.000 description 13
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 13
- 239000003480 eluent Substances 0.000 description 13
- 239000012312 sodium hydride Substances 0.000 description 13
- 229910000104 sodium hydride Inorganic materials 0.000 description 13
- QAHVHSLSRLSVGS-UHFFFAOYSA-N sulfamoyl chloride Chemical compound NS(Cl)(=O)=O QAHVHSLSRLSVGS-UHFFFAOYSA-N 0.000 description 13
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- 238000003756 stirring Methods 0.000 description 12
- 108010087999 Steryl-Sulfatase Proteins 0.000 description 11
- 102100038021 Steryl-sulfatase Human genes 0.000 description 11
- 238000000034 method Methods 0.000 description 11
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 10
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 10
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 238000005259 measurement Methods 0.000 description 9
- ATHHXGZTWNVVOU-UHFFFAOYSA-N N-methylformamide Chemical compound CNC=O ATHHXGZTWNVVOU-UHFFFAOYSA-N 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 238000001816 cooling Methods 0.000 description 8
- 238000000746 purification Methods 0.000 description 8
- IIACRCGMVDHOTQ-UHFFFAOYSA-M sulfamate Chemical compound NS([O-])(=O)=O IIACRCGMVDHOTQ-UHFFFAOYSA-M 0.000 description 8
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 238000001914 filtration Methods 0.000 description 7
- JKKFKPJIXZFSSB-UHFFFAOYSA-N 1,3,5(10)-estratrien-17-one 3-sulfate Natural products OS(=O)(=O)OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 JKKFKPJIXZFSSB-UHFFFAOYSA-N 0.000 description 6
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 6
- PJUPKRYGDFTMTM-UHFFFAOYSA-N 1-hydroxybenzotriazole;hydrate Chemical compound O.C1=CC=C2N(O)N=NC2=C1 PJUPKRYGDFTMTM-UHFFFAOYSA-N 0.000 description 6
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 6
- JKKFKPJIXZFSSB-CBZIJGRNSA-N estrone 3-sulfate Chemical compound OS(=O)(=O)OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 JKKFKPJIXZFSSB-CBZIJGRNSA-N 0.000 description 6
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 5
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 238000004587 chromatography analysis Methods 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 229910052744 lithium Inorganic materials 0.000 description 5
- 239000011777 magnesium Substances 0.000 description 5
- 229910052749 magnesium Inorganic materials 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 5
- 238000004809 thin layer chromatography Methods 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- BHHGXPLMPWCGHP-UHFFFAOYSA-N Phenethylamine Chemical compound NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 description 4
- 150000001408 amides Chemical class 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 150000001718 carbodiimides Chemical class 0.000 description 4
- 229940011871 estrogen Drugs 0.000 description 4
- 239000000262 estrogen Substances 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 210000002826 placenta Anatomy 0.000 description 4
- 229910000033 sodium borohydride Inorganic materials 0.000 description 4
- 239000012279 sodium borohydride Substances 0.000 description 4
- 239000000052 vinegar Substances 0.000 description 4
- 235000021419 vinegar Nutrition 0.000 description 4
- CQJLRERRATXQIE-UHFFFAOYSA-N 2-benzylbutanamide Chemical compound CCC(C(N)=O)CC1=CC=CC=C1 CQJLRERRATXQIE-UHFFFAOYSA-N 0.000 description 3
- KUDDIVFYPCPVPX-UHFFFAOYSA-N 4-(4-phenylmethoxyphenyl)benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C(C=C1)=CC=C1OCC1=CC=CC=C1 KUDDIVFYPCPVPX-UHFFFAOYSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 235000019270 ammonium chloride Nutrition 0.000 description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 3
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 238000001953 recrystallisation Methods 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- AKEJUJNQAAGONA-UHFFFAOYSA-N sulfur trioxide Inorganic materials O=S(=O)=O AKEJUJNQAAGONA-UHFFFAOYSA-N 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- MPWSRGAWRAYBJK-UHFFFAOYSA-N (4-tert-butylphenyl)methanamine Chemical compound CC(C)(C)C1=CC=C(CN)C=C1 MPWSRGAWRAYBJK-UHFFFAOYSA-N 0.000 description 2
- QZNQSIHCDAGZIA-UHFFFAOYSA-N 1-(bromomethyl)-4-tert-butylbenzene Chemical compound CC(C)(C)C1=CC=C(CBr)C=C1 QZNQSIHCDAGZIA-UHFFFAOYSA-N 0.000 description 2
- IEQAICDLOKRSRL-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO IEQAICDLOKRSRL-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- ZSLUVFAKFWKJRC-IGMARMGPSA-N 232Th Chemical compound [232Th] ZSLUVFAKFWKJRC-IGMARMGPSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 2
- 229920000858 Cyclodextrin Polymers 0.000 description 2
- NOTFZGFABLVTIG-UHFFFAOYSA-N Cyclohexylethyl acetate Chemical compound CC(=O)OCCC1CCCCC1 NOTFZGFABLVTIG-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 229910052776 Thorium Inorganic materials 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000012300 argon atmosphere Substances 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- YXVFYQXJAXKLAK-UHFFFAOYSA-N biphenyl-4-ol Chemical group C1=CC(O)=CC=C1C1=CC=CC=C1 YXVFYQXJAXKLAK-UHFFFAOYSA-N 0.000 description 2
- 239000012267 brine Substances 0.000 description 2
- 238000005251 capillar electrophoresis Methods 0.000 description 2
- LJOODBDWMQKMFB-UHFFFAOYSA-N cyclohexylacetic acid Chemical compound OC(=O)CC1CCCCC1 LJOODBDWMQKMFB-UHFFFAOYSA-N 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 239000013024 dilution buffer Substances 0.000 description 2
- 229940080345 gamma-cyclodextrin Drugs 0.000 description 2
- 201000010260 leiomyoma Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- HIPXPABRMMYVQD-UHFFFAOYSA-N n-benzylbutan-1-amine Chemical compound CCCCNCC1=CC=CC=C1 HIPXPABRMMYVQD-UHFFFAOYSA-N 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000011535 reaction buffer Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- WBHQBSYUUJJSRZ-UHFFFAOYSA-M sodium bisulfate Chemical compound [Na+].OS([O-])(=O)=O WBHQBSYUUJJSRZ-UHFFFAOYSA-M 0.000 description 2
- 229910000342 sodium bisulfate Inorganic materials 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- 125000000547 substituted alkyl group Chemical group 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- ZSHCHOYJMLEAOX-UHFFFAOYSA-N 1-(4-tert-butylphenyl)-n-methylmethanamine Chemical compound CNCC1=CC=C(C(C)(C)C)C=C1 ZSHCHOYJMLEAOX-UHFFFAOYSA-N 0.000 description 1
- ICSNLGPSRYBMBD-UHFFFAOYSA-N 2-aminopyridine Chemical compound NC1=CC=CC=N1 ICSNLGPSRYBMBD-UHFFFAOYSA-N 0.000 description 1
- ISCMYZGMRHODRP-UHFFFAOYSA-N 3-(iminomethylideneamino)-n,n-dimethylpropan-1-amine Chemical compound CN(C)CCCN=C=N ISCMYZGMRHODRP-UHFFFAOYSA-N 0.000 description 1
- NYYRRBOMNHUCLB-UHFFFAOYSA-N 3-chloro-n,n-dimethylpropan-1-amine Chemical compound CN(C)CCCCl NYYRRBOMNHUCLB-UHFFFAOYSA-N 0.000 description 1
- ASFAFOSQXBRFMV-LJQANCHMSA-N 3-n-(2-benzyl-1,3-dihydroxypropan-2-yl)-1-n-[(1r)-1-(4-fluorophenyl)ethyl]-5-[methyl(methylsulfonyl)amino]benzene-1,3-dicarboxamide Chemical compound N([C@H](C)C=1C=CC(F)=CC=1)C(=O)C(C=1)=CC(N(C)S(C)(=O)=O)=CC=1C(=O)NC(CO)(CO)CC1=CC=CC=C1 ASFAFOSQXBRFMV-LJQANCHMSA-N 0.000 description 1
- YFCIFWOJYYFDQP-PTWZRHHISA-N 4-[3-amino-6-[(1S,3S,4S)-3-fluoro-4-hydroxycyclohexyl]pyrazin-2-yl]-N-[(1S)-1-(3-bromo-5-fluorophenyl)-2-(methylamino)ethyl]-2-fluorobenzamide Chemical compound CNC[C@@H](NC(=O)c1ccc(cc1F)-c1nc(cnc1N)[C@H]1CC[C@H](O)[C@@H](F)C1)c1cc(F)cc(Br)c1 YFCIFWOJYYFDQP-PTWZRHHISA-N 0.000 description 1
- WRDWWAVNELMWAM-UHFFFAOYSA-N 4-tert-butylaniline Chemical compound CC(C)(C)C1=CC=C(N)C=C1 WRDWWAVNELMWAM-UHFFFAOYSA-N 0.000 description 1
- JLLYLQLDYORLBB-UHFFFAOYSA-N 5-bromo-n-methylthiophene-2-sulfonamide Chemical compound CNS(=O)(=O)C1=CC=C(Br)S1 JLLYLQLDYORLBB-UHFFFAOYSA-N 0.000 description 1
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 102100033040 Carbonic anhydrase 12 Human genes 0.000 description 1
- XJUZRXYOEPSWMB-UHFFFAOYSA-N Chloromethyl methyl ether Chemical compound COCCl XJUZRXYOEPSWMB-UHFFFAOYSA-N 0.000 description 1
- 101000867855 Homo sapiens Carbonic anhydrase 12 Proteins 0.000 description 1
- 101000879758 Homo sapiens Sjoegren syndrome nuclear autoantigen 1 Proteins 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- CZWCKYRVOZZJNM-UHFFFAOYSA-N Prasterone sodium sulfate Natural products C1C(OS(O)(=O)=O)CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CC=C21 CZWCKYRVOZZJNM-UHFFFAOYSA-N 0.000 description 1
- 102100037330 Sjoegren syndrome nuclear autoantigen 1 Human genes 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- RVKFQAJIXCZXQY-CBZIJGRNSA-N [(8r,9s,13s,14s)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthren-3-yl] sulfamate Chemical compound NS(=O)(=O)OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 RVKFQAJIXCZXQY-CBZIJGRNSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- UPABQMWFWCMOFV-UHFFFAOYSA-N benethamine Chemical compound C=1C=CC=CC=1CNCCC1=CC=CC=C1 UPABQMWFWCMOFV-UHFFFAOYSA-N 0.000 description 1
- ZPHQBFRCXUIIAZ-UHFFFAOYSA-N benzene;hydrochloride Chemical compound Cl.C1=CC=CC=C1 ZPHQBFRCXUIIAZ-UHFFFAOYSA-N 0.000 description 1
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- RBHJBMIOOPYDBQ-UHFFFAOYSA-N carbon dioxide;propan-2-one Chemical compound O=C=O.CC(C)=O RBHJBMIOOPYDBQ-UHFFFAOYSA-N 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- CZWCKYRVOZZJNM-USOAJAOKSA-N dehydroepiandrosterone sulfate Chemical compound C1[C@@H](OS(O)(=O)=O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC=C21 CZWCKYRVOZZJNM-USOAJAOKSA-N 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- FYXQIMAAEMCZLV-UHFFFAOYSA-N ethyl 4-(4-hydroxyphenyl)benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1C1=CC=C(O)C=C1 FYXQIMAAEMCZLV-UHFFFAOYSA-N 0.000 description 1
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 1
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- CETVQRFGPOGIQJ-UHFFFAOYSA-N lithium;hexane Chemical compound [Li+].CCCCC[CH2-] CETVQRFGPOGIQJ-UHFFFAOYSA-N 0.000 description 1
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- XONPDZSGENTBNJ-UHFFFAOYSA-N molecular hydrogen;sodium Chemical compound [Na].[H][H] XONPDZSGENTBNJ-UHFFFAOYSA-N 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- QAXZWHGWYSJAEI-UHFFFAOYSA-N n,n-dimethylformamide;ethanol Chemical compound CCO.CN(C)C=O QAXZWHGWYSJAEI-UHFFFAOYSA-N 0.000 description 1
- MZRVEZGGRBJDDB-UHFFFAOYSA-N n-Butyllithium Substances [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 1
- VSHTWPWTCXQLQN-UHFFFAOYSA-N n-butylaniline Chemical compound CCCCNC1=CC=CC=C1 VSHTWPWTCXQLQN-UHFFFAOYSA-N 0.000 description 1
- ABRWESLGGMHKEA-UHFFFAOYSA-N n-tert-butylaniline Chemical compound CC(C)(C)NC1=CC=CC=C1 ABRWESLGGMHKEA-UHFFFAOYSA-N 0.000 description 1
- XYEOALKITRFCJJ-UHFFFAOYSA-N o-benzylhydroxylamine Chemical compound NOCC1=CC=CC=C1 XYEOALKITRFCJJ-UHFFFAOYSA-N 0.000 description 1
- IOQPZZOEVPZRBK-UHFFFAOYSA-N octan-1-amine Chemical compound CCCCCCCCN IOQPZZOEVPZRBK-UHFFFAOYSA-N 0.000 description 1
- WUFMLQXDPIZFIF-UHFFFAOYSA-N octyl 4-(4-hydroxyphenyl)benzoate Chemical compound C1=CC(C(=O)OCCCCCCCC)=CC=C1C1=CC=C(O)C=C1 WUFMLQXDPIZFIF-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 229950009829 prasterone sulfate Drugs 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- JWHOQZUREKYPBY-UHFFFAOYSA-N rubonic acid Natural products CC1(C)CCC2(CCC3(C)C(=CCC4C5(C)CCC(=O)C(C)(C)C5CC(=O)C34C)C2C1)C(=O)O JWHOQZUREKYPBY-UHFFFAOYSA-N 0.000 description 1
- 239000012146 running buffer Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- IIACRCGMVDHOTQ-UHFFFAOYSA-N sulfamic acid Chemical class NS(O)(=O)=O IIACRCGMVDHOTQ-UHFFFAOYSA-N 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
【発明の属する技術分野】本発明は新規ビフェニル誘導
体に関する。更に詳しくは、ステロイドスルファターゼ
阻害剤として有用な次式(I)[0001] The present invention relates to a novel biphenyl derivative. More specifically, the following formula (I) useful as a steroid sulfatase inhibitor
【化2】 (式中Rは、−COOH、−CONR1R2、−CON
R1OCH2C6H5、−COR2または−C(OH)
R1R2を表し、R1は、水素原子または置換基を有す
ることもあるアルキル基を表し、R2は、置換基を有す
ることもあるアルキル基を表す。)で示される新規ビフ
ェニル誘導体に関する。Embedded image (Wherein R is -COOH, -CONR 1 R 2 , -CON
R 1 OCH 2 C 6 H 5 , —COR 2 or —C (OH)
R 1 represents R 2 , R 1 represents a hydrogen atom or an alkyl group which may have a substituent, and R 2 represents an alkyl group which may have a substituent. )).
【従来の技術】乳癌、子宮内膜癌、子宮内膜症および子
宮筋腫などは、エストロゲン依存性疾患として知られて
おり、これらの組織中のエストロゲン濃度を低下させる
ことおよびエストロゲン作用を抑制することがこれら疾
病の治療に有効であると考えられている。そのため、エ
ストロゲンの産生を抑制する目的で、ステロイドスルフ
ァターゼ(EC3.1.6.2)の阻害剤が注目され、
リード(Reed)等により種々検討が行われている。
例えば、USP5,556,847には、エストロン−
3−O−スルファメート(EMATE)などのスルファ
メート誘導体が、ステロイドスルファターゼ阻害剤とし
て有用であることが開示されている。また、WO97/
30041には、下式(II)で示される化合物(CO
UMATE)などのスルファメート誘導体が知られてお
り、2. Description of the Related Art Breast cancer, endometrial cancer, endometriosis and uterine fibroids are known as estrogen-dependent diseases, and the estrogen concentration in these tissues is reduced and the estrogen action is suppressed. Are thought to be effective in treating these diseases. Therefore, steroid sulfatase (EC 3.1.6.2) inhibitors have been attracting attention for the purpose of suppressing estrogen production.
Various studies have been made with Reed and the like.
For example, US Pat.
It has been disclosed that sulfamate derivatives such as 3-O-sulfamate (EMATE) are useful as steroid sulfatase inhibitors. In addition, WO97 /
The compound represented by the following formula (II) (CO
UMATE) are known.
【化3】 また、WO97/06793には、下式(III)が、Embedded image WO 97/06793 describes the following formula (III):
【化4】 ステロイドスルファターゼ阻害剤として有用であること
が開示されている。しかし、ステロイドスルファターゼ
阻害作用を有するビフェニル誘導体については、全く知
られていない。Embedded image It is disclosed that it is useful as a steroid sulfatase inhibitor. However, biphenyl derivatives having a steroid sulfatase inhibitory action are not known at all.
【発明が解決しようとする課題】本発明の目的は、ステ
ロイドスルファターゼ阻害剤として有用な新規な化合物
を提供することにある。An object of the present invention is to provide a novel compound useful as a steroid sulfatase inhibitor.
【課題を解決するための手段】本発明者等は種々検討を
重ねた結果、前記式(I)で示される新規ビフェニル誘
導体が、上記の目的に適うことを見い出して本発明を完
成させた。As a result of various studies, the present inventors have found that the novel biphenyl derivative represented by the above formula (I) meets the above-mentioned object, and completed the present invention.
【発明の実施の形態】前記式(I)においてR1、R2
のアルキル基としては、例えば、メチル基、エチル基、
プロピル基、オクチル基などの直鎖アルキル基が挙げら
れ、これらアルキル基は適宜置換基を有していても良
い。置換アルキル基の置換基としては、例えば低級アル
キル基で置換されていてもよいフェニル基が挙げられ
る。ここでいう低級アルキル基としては、例えばメチル
基、エチル基、プロピル基、イソプロピル基、ブチル
基、t−ブチル基などが挙げられる。置換位置としては
4位が好ましい。特に好ましい置換アルキル基として
は、4−t−ブチルベンジル基が挙げられる。また、前
記式(I)において、立体異性体が存在するが、これら
の立体異性体およびこれらの混合物も本発明の化合物に
包含される。また、本発明のビフェニル誘導体の具体例
としては、以下の化合物が挙げられる。 4’−アセチルビフェニル−4−イル スルファメート 4’−[2−(4−t−ブチルフェニル)−アセチル]
−ビフェニル−4−イルスルファメート 4’−(n−ペンタノイル)−ビフェニル−4−イル
スルファメート 4’−(n−ヘプタノイル)−ビフェニル−4−イル
スルファメート 4’−(エチルカルバモイル)−ビフェニル−4−イル
スルファメート 4’−(オクチルカルバモイル)−ビフェニル−4−イ
ル スルファメート 4’−(2−フェネチルカルバモイル)−ビフェニル−
4−イル スルファメート 4’−(4−t−ブチルベンジルカルバモイル)−ビフ
ェニル−4−イルスルファメート 4’−(4−t−ブチルフェニルカルバモイル)−ビフ
ェニル−4−イルスルファメート 4’−(ベンジルオキシカルバモイル)−ビフェニル−
4−イル スルファメート 4’−(ベンジルメチルカルバモイル)−ビフェニル−
4−イル スルファメート 4’−[(4−t−ブチルベンジル)メチルカルバモイ
ル]−ビフェニル−4−イル スルファメート 4’−(ベンジルブチルカルバモイル)−ビフェニル−
4−イル スルファメート 4’−[(4−t−ブチルベンジル)オクチルカルバモ
イル]ビフェニル−4−イル スルファメート 4’−(スルファモイルオキシ)−ビフェニル−4−カ
ルボン酸 4’−(1RS−ヒドロキシエチル)−ビフェニル−4
−イル スルファメート 4’−[2−(4−t−ブチルフェニル)−1RS−ヒ
ドロキシエチル]−ビフェニル−4−イル スルファメ
ート 4’−[2−(4−t−ブチルフェニル)−1RS−ヒ
ドロキシ−1−メチルエチル]−ビフェニル−4−イル
スルファメート 本発明のビフェニル誘導体は、以下のA法、B法のいず
れかの方法によって製造できる。 [A法]本発明のビフェニル誘導体(I)で示される化
合物は以下の方法によって製造することができる。BEST MODE FOR CARRYING OUT THE INVENTION In the above formula (I), R 1 , R 2
Examples of the alkyl group include a methyl group, an ethyl group,
Examples thereof include linear alkyl groups such as a propyl group and an octyl group, and these alkyl groups may have a substituent as appropriate. Examples of the substituent of the substituted alkyl group include a phenyl group which may be substituted with a lower alkyl group. Examples of the lower alkyl group include a methyl group, an ethyl group, a propyl group, an isopropyl group, a butyl group and a t-butyl group. The substitution position is preferably the 4-position. A particularly preferred substituted alkyl group is a 4-t-butylbenzyl group. In the formula (I), stereoisomers exist, and these stereoisomers and a mixture thereof are also included in the compound of the present invention. Further, specific examples of the biphenyl derivative of the present invention include the following compounds. 4'-acetylbiphenyl-4-yl sulfamate 4 '-[2- (4-t-butylphenyl) -acetyl]
-Biphenyl-4-ylsulfamate 4 '-(n-pentanoyl) -biphenyl-4-yl
Sulfamate 4 '-(n-heptanoyl) -biphenyl-4-yl
Sulfamate 4 '-(ethylcarbamoyl) -biphenyl-4-yl sulfamate 4'-(octylcarbamoyl) -biphenyl-4-yl sulfamate 4 '-(2-phenethylcarbamoyl) -biphenyl-
4-yl sulfamate 4 '-(4-t-butylbenzylcarbamoyl) -biphenyl-4-ylsulfamate 4'-(4-t-butylphenylcarbamoyl) -biphenyl-4-ylsulfamate 4 '-(benzyloxy Carbamoyl) -biphenyl-
4-yl sulfamate 4 '-(benzylmethylcarbamoyl) -biphenyl-
4-yl sulfamate 4 '-[(4-t-butylbenzyl) methylcarbamoyl] -biphenyl-4-yl sulfamate 4'-(benzylbutylcarbamoyl) -biphenyl-
4-yl sulfamate 4 '-[(4-t-butylbenzyl) octylcarbamoyl] biphenyl-4-yl sulfamate 4'-(sulfamoyloxy) -biphenyl-4-carboxylic acid 4 '-(1RS-hydroxyethyl) -Biphenyl-4
-Yl sulfamate 4 '-[2- (4-t-butylphenyl) -1RS-hydroxyethyl] -biphenyl-4-yl sulfamate 4'-[2- (4-t-butylphenyl) -1RS-hydroxy-1 -Methylethyl] -biphenyl-4-yl sulfamate The biphenyl derivative of the present invention can be produced by any of the following methods A and B. [Method A] The compound represented by the biphenyl derivative (I) of the present invention can be produced by the following method.
【化5】 (式中、Rは前記に同じ。) 本発明化合物(I)は、N,N−ジメチルホルムアミド
中、化合物(IV)と水素化ナトリウムとを5〜50℃
で20分〜24時間攪拌した後、0℃〜30℃で、スル
ファモイルクロライドを添加し、0.5〜24時間反応
させることにより製造することができる。水素化ナトリ
ウムは、化合物(IV)に対して通常1〜1.5当量使
用される。また、スルファモイルクロライドは、化合物
(IV)に対して通常1〜5当量使用される。 [B法]また、本発明のビフェニル誘導体(I)のう
ち、Rが−CH(OH)R2で表される化合物(I’)
は、以下の方法によっても製造することができる。Embedded image (In the formula, R is the same as described above.) The compound (I) of the present invention is prepared by converting the compound (IV) and sodium hydride in N, N-dimethylformamide at 5 to 50 ° C.
After stirring for 20 minutes to 24 hours at 0 ° C. to 30 ° C., sulfamoyl chloride is added, and the mixture is allowed to react for 0.5 to 24 hours. Sodium hydride is generally used in the amount of 1 to 1.5 equivalents based on compound (IV). Sulfamoyl chloride is usually used in an amount of 1 to 5 equivalents based on compound (IV). [Method B] Further, among the biphenyl derivatives (I) of the present invention, compounds (I ′) in which R is represented by —CH (OH) R 2
Can also be produced by the following method.
【化6】 (式中、Raは−COR2を表し、R2は前記に同
じ。) 本発明化合物(I’)は、A法で得られた化合物(I)
のうち、Rが−COR2で表されるものをメタノール、
エタノールなどの低級アルコール、水もしくはこれらの
混合溶媒中、水素化ホウ素ナトリウムと0℃〜30℃
で、0.5〜24時間反応させることにより製造するこ
とができる。水素化ホウ素ナトリウムは、化合物(I
a)に対して通常1〜5当量使用される。上記A法、B
法により得られる本発明化合物(I)は、必要に応じ
て、含水アルコールなどの含水溶媒から再結晶すること
によりそれら化合物の水和物に導くこともできる。光学
活性な本発明の化合物(I)は、上記製造法によって得
られる化合物(I)の立体異性体混合物から常法に従っ
て分離精製することにより得ることができる。Embedded image (In the formula, Ra represents —COR 2 , and R 2 is the same as described above.) The compound (I ′) of the present invention is a compound (I) obtained by Method A.
Among them, those in which R is represented by -COR 2 are methanol,
In a lower alcohol such as ethanol, water or a mixed solvent thereof, sodium borohydride and 0 ° C to 30 ° C
And reacting for 0.5 to 24 hours. Sodium borohydride is compound (I)
It is usually used in an amount of 1 to 5 equivalents to a). Method A, B above
The compound (I) of the present invention obtained by the method can be converted into a hydrate of the compound by recrystallization from a water-containing solvent such as a water-containing alcohol, if necessary. The optically active compound (I) of the present invention can be obtained by separating and purifying from a stereoisomer mixture of the compound (I) obtained by the above-mentioned production method according to a conventional method.
【発明の効果】本発明化合物はステロイドスルファター
ゼによるエストロン硫酸(E1S)からエストロン(E
1)への変換を強く阻害する(後記試験例1参照)。従
って、本発明化合物は、ステロイドスルファターゼ阻害
剤として、エストロン依存性疾患、例えば乳癌、子宮内
膜癌、子宮内膜症および子宮筋腫などに効果を示す。 試験例1ステロイドスルファターゼ阻害活性の測定: (1)試験化合物:実施例2、7、8、10の化合物 (2)試験方法:被験化合物のステロイドスルファター
ゼ阻害活性の測定は、被験化合物存在下で、ヒト胎盤由
来の精製ステロイドスルファターゼによるE1SからE
1への変換がどの程度阻害されるかを測定することによ
り実施した(ヒト胎盤由来のステロイドスルファターゼ
は、E1Sおよびデヒドロエピアンドロステロン硫酸の
両方を加水分解することが報告されている)。被験化合
物は、ジメチルスルフォキシドにより10mMの濃度に
溶解した。これを反応緩衝液(0.1%Brij−35
を含む50mMトリス塩酸緩衝液pH7.4)にて12
0μMの濃度に希釈した。更に、希釈緩衝液(0.1%
Brij−35,1.2%ジメチルスルフォキシドを含
む50mMトリス塩酸緩衝液pH7.4)にて適宜希釈
して被験化合物溶液を調製した。この被験化合物溶液5
0μLに反応緩衝液にて調製した40μMのE1S溶液
100μLとスズキ(Suzuki)等の方法[Pur
ification and Properties
of Steroid Sulfatase from
Human Placenta,Endoclino
l.Japon,39:93−101.(1992)]
によりヒト胎盤より精製し反応緩衝液にて0.2μg/
mLに調製したステロイドスルファターゼ溶液50μL
を混合し、37℃にて60分間反応させた。反応終了
後、100℃、1分間の加熱処理にてステロイドスルフ
ァターゼを失活させ、3,000回転、5分間遠心分離
した上清を測定試料とした。阻害活性は、測定試料をキ
ャピラリー電気泳動にて分析し、反応により生成された
E1のピーク面積から評価した。即ち、被験化合物溶液
の代わりに希釈緩衝液を用いて同様に処理して得られた
測定用試料(コントロール測定試料)のピーク面積と、
各濃度の被検化合物溶液を用いた場合のピーク面積を求
め、次式により各々の阻害%を算出した。更に、被験化
合物の濃度と、阻害%からプロビット法にて50%阻害
濃度(IC50)を算出した。EFFECT OF THE INVENTION The compounds of the present invention can be converted from estrone sulfate (E1S) by steroid sulfatase to estrone (E
It strongly inhibits conversion to 1) (see Test Example 1 described later). Therefore, the compounds of the present invention are effective as steroid sulfatase inhibitors against estrone-dependent diseases such as breast cancer, endometrial cancer, endometriosis and uterine fibroids. Test Example 1 Measurement of Steroid Sulfatase Inhibitory Activity: (1) Test compound: compounds of Examples 2, 7, 8, and 10 (2) Test method: Measurement of steroid sulfatase inhibitory activity of a test compound was performed in the presence of the test compound. E1S to E by purified steroid sulfatase from human placenta
This was performed by measuring the extent to which the conversion to 1 was inhibited (steroid placentas from human placenta have been reported to hydrolyze both E1S and dehydroepiandrosterone sulfate). The test compound was dissolved with dimethyl sulfoxide to a concentration of 10 mM. This was added to a reaction buffer (0.1% Brij-35).
In 50 mM Tris-HCl buffer (pH 7.4) containing
Diluted to a concentration of 0 μM. Further, a dilution buffer (0.1%
Brij-35, a 50 mM Tris-HCl buffer (pH 7.4) containing 1.2% dimethyl sulfoxide was appropriately diluted to prepare a test compound solution. This test compound solution 5
100 μL of a 40 μM E1S solution prepared in a reaction buffer to 0 μL and a method such as Suzuki [Pur
ififation and Properties
of Steroid Sulfatase from
Human Placenta, Endoclino
l. Japan, 39: 93-101. (1992)]
And purified with 0.2 μg /
50 μL of steroid sulfatase solution prepared in mL
And reacted at 37 ° C. for 60 minutes. After the reaction was completed, the steroid sulfatase was inactivated by heating at 100 ° C. for 1 minute, and the supernatant obtained by centrifugation at 3,000 rpm for 5 minutes was used as a measurement sample. The inhibitory activity was determined by analyzing a measurement sample by capillary electrophoresis and evaluating the peak area of E1 generated by the reaction. That is, the peak area of a measurement sample (control measurement sample) obtained by performing the same treatment using a dilution buffer instead of the test compound solution,
The peak area when the test compound solution of each concentration was used was determined, and each inhibition% was calculated by the following formula. Further, a 50% inhibitory concentration (IC 50 ) was calculated from the concentration of the test compound and the inhibition% by the probit method.
【数1】阻害%=(1−S/C)×100 S : 被験化合物測定試料のピーク面積 C : コントロール測定試料のピーク面積 キャピラリー電気泳動法は、次に示す方法により実施し
た。即ち、泳動装置にベックマン社P/ACE5010
を、キャピラリーは内径50μm、全長37cmのもの
を、泳動緩衝液は20mMγ−シクロデキストリン、5
0mMドデシル硫酸ナトリウムを含む10mMのホウ酸
緩衝液(pH9.0)を用い、試料注入後25kV、
2.5分間の泳動を行った。試料注入は5秒間の圧力注
入にて行い、検出は200nmの紫外部吸収にて行っ
た。なお、試料注入前に、0.1N水酸化ナトリウムに
て1分間のキャピラリー洗浄、泳動緩衝液による1分間
のキャピラリー平衡化を行った。測定試料には、分析前
に試料量20μLあたり5μLの40mM−γ−シクロ
デキストリン/0.1Mホウ酸緩衝液(pH9.0)を
添加した。 (2)試験結果結果は、表1に示した。## EQU1 ## Inhibition% = (1-S / C) × 100 S: peak area of test compound measurement sample C: peak area of control measurement sample Capillary electrophoresis was performed by the following method. That is, P / ACE5010 from Beckman was used in the electrophoresis apparatus.
And a capillary having an inner diameter of 50 μm and a total length of 37 cm, and a running buffer of 20 mM γ-cyclodextrin,
Using a 10 mM borate buffer (pH 9.0) containing 0 mM sodium dodecyl sulfate, 25 kV after the sample injection,
The electrophoresis was performed for 2.5 minutes. Sample injection was performed by pressure injection for 5 seconds, and detection was performed by ultraviolet absorption at 200 nm. Before the sample injection, the capillary was washed with 0.1 N sodium hydroxide for 1 minute, and the capillary was equilibrated with an electrophoresis buffer for 1 minute. Before the analysis, 5 μL of 40 mM-γ-cyclodextrin / 0.1 M borate buffer (pH 9.0) was added to the measurement sample per 20 μL of the sample. (2) Test results The results are shown in Table 1.
【表1】 表1に示される通り、本発明化合物は、ステロイドスル
ファターゼによるE1SからE1への変換を阻害した。[Table 1] As shown in Table 1, the compounds of the present invention inhibited the conversion of E1S to E1 by steroid sulfatase.
【実施例】以下に、実施例および参考例を挙げて、本発
明を更に具体的に説明する。 実施例14’−アセチルビフェニル−4−イル スルファメート 1−(4’−ヒドロキシビフェニル−4−イル)−エタ
ノン(参考例1参照)100mgのN,N−ジメチルホ
ルムアミド2mL溶液に、60%水素化ナトリウム(油
性)20mgを加え20分間撹拌した。さらにスルファ
モイルクロリド110mgを加え1.5時間撹拌した。
反応混合物を氷水に注ぎ、酢酸エチルで抽出し、4回水
洗した。得られた酢酸エチル溶液を無水硫酸ナトリウム
で乾燥した後減圧下に乾固した。得られた残渣を薄層ク
ロマトグラフィーで精製(展開液:クロロホルム:アセ
トン=100:16)し、得られた結晶をシクロヘキサ
ン−酢酸エチルの混合溶媒から再結晶し、4’−アセチ
ルビフェニル−4−イルスルファメートの結晶38mg
を得た。 m.p.184.0−184.5℃1 H NMR(DMSO−d6):δ 2.60(3
H,s),7.38(2H,m),7.84(4H,
m),8.03(2H,m),8.05(2H,s). 元素分析(C14H13NO4Sとして) 計算値(%):C,57.72;H,4.50;N,
4.81 分析値(%):C,57.61;H,4.45;N,
4.74 実施例24’−[2−(4−t−ブチルフェニル)−アセチル]
−ビフェニル−4−イルスルファメート 2−(4−t−ブチルフェニル)−1−(4’−ヒドロ
キシビフェニル−4−イル)−エタノン(参考例5参
照)0.62gのN,N−ジメチルホルムアミド20m
L溶液に、60%水素化ナトリウム(油性) 86mg
を加え30分間撹拌した。さらにスルファモイルクロリ
ド0.415gを加え、室温で2時間撹拌した。反応混
合物を氷水に注ぎ、酢酸エチルで抽出し、4回水洗し
た。得られた酢酸エチル溶液を無水硫酸ナトリウムで乾
燥した後減圧下に乾固した。得られた残渣を中圧カラム
クロマトで精製(溶出液:ヘキサン:酢酸エチル=2:
1)し、得られた結晶をシクロヘキサン−酢酸エチル混
合溶媒から再結晶し、4’−[2−(4−t−ブチルフ
ェニル)−アセチル]−ビフェニル−4−イル スルフ
ァメートの結晶0.39gを得た。 m.p.163−164℃1 H NMR(DMSO−d6):δ 1.26(9
H,s),4.37(2H,s),7.21(2H,
m),7.37(4H,m),7.84(4H,m),
8.12(4H,m). 実施例34’−(n−ペンタノイル)−ビフェニル−4−イル
スルファメート 1−(4’−ヒドロキシビフェニル−4−イル)−ペン
タン−1−オン(参考例6参照)0.5gのN,N−ジ
メチルホルムアミド5mL溶液に、60%水素化ナトリ
ウム(油性) 87mgを加え1時間撹拌した。さらに
氷冷下スルファモイルクロリド570mgを加え、室温
で18時間撹拌した。反応混合物を氷水に注ぎ、酢酸エ
チルで抽出し、4回水洗した。得られた酢酸エチル溶液
を無水硫酸マグネシウムで乾燥した後減圧下に乾固し
た。得られた残渣を中圧シリカゲルクロマトで精製(溶
出液:クロロホルム:メタノール=99:1)し、得ら
れた結晶をメタノールから再結晶し、4’−(n−ペン
タノイル)−ビフェニル−4−イル スルファメートの
結晶0.37gを得た。 m.p.172−174℃1 H NMR(DMSO−d6):δ 0.92(3
H,t,J=7Hz),1.38(2H,m),1.6
2(2H,m),3.05(2H,t,J=6Hz),
7.40(2H,m),7.83(4H,m),8.0
5(4H,m).元素分析(C17H19NO4Sとし
て) 計算値(%):C,61.24;H,5.74;N,
4.20 分析値(%):C,61.38;H,5.83;N,
4.29 実施例44’−(n−ヘプタノイル)−ビフェニル−4−イル
スルファメート 1−(4’−ヒドロキシビフェニル−4−イル)−ヘプ
タン−1−オン(参考例7参照)0.6gのN,N−ジ
メチルホルムアミド10mL溶液に、60%水素化ナト
リウム(油性) 102mgを加え1時間撹拌した。さ
らに氷冷下スルファモイルクロリド0.5gを加え、室
温で20時間撹拌した。反応混合物を氷水に注ぎ、酢酸
エチルで抽出し、4回水洗した。得られた酢酸エチル溶
液を無水硫酸マグネシウムで乾燥した後減圧下に乾固し
た。得られた残渣を中圧シリカゲルクロマトで精製(溶
出液:クロロホルム:メタノール=99:1)し、4’
−(n−ペンタノイル)−ビフェニル−4−イル スル
ファメートの結晶0.37gを得た。 m.p.172−174℃1 H NMR(DMSO−d6):δ 0.87(3
H,t,J:7Hz),1.2−1.5(6H,m),
1.62(2H,m),3.04(2H,t,J=7.
2Hz),7.40(2H,m),7.84(4H,
m),8.07(4H,m). 元素分析(C19H23NO4Sとして) 計算値(%):C,63.13;H,6.41;N,
3.88 分析値(%):C,63.38;H,6.56;N,
3.85 実施例54’−(エチルカルバモイル)−ビフェニル−4−イル
スルファメート 4’−ヒドロキシビフェニル−4−カルボン酸エチルア
ミド(参考例8参照)0.3gのN,N−ジメチルホル
ムアミド10mL溶液に、60%水素化ナトリウム(油
性)105mgを加え30分間撹拌した。さらにスルフ
ァモイルクロリド520mgを加え、室温で17時間撹
拌した。反応混合物を氷水に注ぎ、酢酸エチルで抽出
し、4回水洗した。得られた酢酸エチル溶液を無水硫酸
マグネシウムで乾燥した後減圧下に乾固した。得られた
残渣をヘキサン−酢酸エチル混合溶媒から再結晶し、
4’−(エチルカルバモイル)−ビフェニル−4−イル
スルファメートの結晶125mgを得た。1 H NMR(DMSO−d6):δ 1.13(3
H,t,J=7.1Hz),3.29(2H,m),
7.37(2H,m),7.78(4H,m),7.9
4(4H,m),8.49(3H,t,J=5.9H
z). 元素分析(C15H16N2O4Sとして) 計算値(%):C,56.24;H,5.03;N,
8.74 分析値(%):C,56.22;H,5.04;N,
8.67 実施例64’−(オクチルカルバモイル)−ビフェニル−4−イ
ル スルファメート 4’−ヒドロキシビフェニル−4−カルボン酸オクチル
アミド(参考例9参照)0.5gのN,N−ジメチルホ
ルムアミド5mL溶液に、60%水素化ナトリウム(油
性)70mgを加え1時間撹拌した。さらに氷冷下スル
ファモイルクロリド445mgを加え、室温で18時間
撹拌した。反応混合物を氷水に注ぎ、酢酸エチルで抽出
し、4回水洗した。得られた酢酸エチル溶液を無水硫酸
マグネシウムで乾燥した後減圧下に乾固した。得られた
残渣を中圧カラムクロマトで精製(溶出液:クロロホル
ム:メタノール=95:5)し、4’−(オクチルカル
バモイル)−ビフェニル−4−イル スルファメート
0.34gを得た。 m.p.212−214℃1 H NMR(DMSO−d6):δ 0.86(3
H,t,J=6.9Hz),1.27(10H,m),
1.52(2H,m),3.25(2H,t,J=6.
9Hz),7.40(2H,m),7.80(4H,
m),7.93(2H,m),8.04(2H,s),
8.42(1H,d,J=5.4Hz). 元素分析(C21H28N2O4Sとして) 計算値(%):C,62.35;H,6.98;N,
6.93 分析値(%):C,62.08;H,7.00;N,
6.89 実施例74’−(2−フェネチルカルバモイル)−ビフェニル−
4−イル スルファメート 4’−ヒドロキシビフェニル−4−カルボン酸2−フェ
ネチルアミド(参考例10参照)0.5gのN,N−ジ
メチルホルムアミド10mL溶液に、60%水素化ナト
リウム(油性)76mgを加え1時間撹拌した。さらに
スルファモイルクロリド0.37gを加え、室温で2時
間撹拌した。反応混合物を氷水に注ぎ、酢酸エチルで抽
出し、4回水洗した。得られた酢酸エチル溶液を無水硫
酸ナトリウムで乾燥した後減圧下に乾固した。得られた
残渣を薄層クロマトグラフィーで精製(展開液:クロロ
ホルム:アセトン=10:1)し、得られた結晶をメタ
ノールから再結晶し、4’−(2−フェネチルカルバモ
イル)−ビフェニル−4−イル スルファメートの結晶
0.1gを得た。 m.p.250℃以上1 H NMR(DMSO−d6):δ 2.86(2
H,t,J=7.9Hz),3.50(2H,m),
7.1−7.4(7H,m),7.80(4H,m),
7.92(2H,m),8.08(2H,s),8.6
4(1H,m). 元素分析(C21H20N2O4Sとして) 計算値(%):C,63.62;H,5.08;N,
7.07 分析値(%):C,63.96;H,5.10;N,
6.96 実施例84’−(4−t−ブチルベンジルカルバモイル)−ビフ
ェニル−4−イル スルファメート 4’−ヒドロキシビフェニル−4−カルボン酸4−t−
ブチルベンジルアミド(参考例11参照)0.5gの
N,N−ジメチルホルムアミド10mL溶液に、60%
水素化ナトリウム(油性)66mgを加え1時間撹拌し
た。さらにスルファモイルクロリド0.32gを加え、
室温で2時間撹拌した。反応混合物を氷水に注ぎ、酢酸
エチルで抽出し、4回水洗した。得られた酢酸エチル溶
液を無水硫酸ナトリウムで乾燥した後減圧下に乾固し
た。得られた残渣を薄層クロマトグラフィーで精製(展
開液:クロロホルム:アセトン=10:1)し、得られ
た結晶を酢酸エチルから再結晶し、4’−(4−t−ブ
チルベンジルカルバモイル)−ビフェニル−4−イル
スルファメートの結晶0.19gを得た。 m.p.201−202℃1 H NMR(DMSO−d6):δ 1.26(9
H,s),4.46(2H,d,J=5.9Hz),
7.25(2H,m),7.37(4H,m),7.8
0(4H,m),7.86(2H,m),8.08(2
H,s),9.1(1H,m). 元素分析(C24H26N2O4Sとして) 計算値(%):C,65.73;H,5.98;N,
6.39 分析値(%) :C,65.73,H,5.96;N,
6.35 実施例94’−(4−t−ブチルフェニルカルバモイル)−ビフ
ェニル−4−イル スルファメート 4’−ヒドロキシビフェニル−4−カルボン酸4−t−
ブチルフェニルアミド(参考例12参照)0.5gの
N,N−ジメチルホルムアミド10mL溶液に、60%
水素化ナトリウム(油性)68mgを加え1.5時間撹
拌した。さらにスルファモイルクロリド0.32gを加
え、室温で2時間撹拌した。反応混合物を氷水に注ぎ、
酢酸エチルで抽出し、4回水洗した。得られた酢酸エチ
ル溶液を無水硫酸ナトリウムで乾燥した後減圧下に乾固
した。得られた残渣を中圧カラムクロマトで精製(溶出
液:ヘキサン:酢酸エチル=3:1〜2:1)し、得ら
れた結晶をシクロヘキサン−酢酸エチル混合溶媒から再
結晶し、4’−(4−t−ブチルフェニルカルバモイ
ル)−ビフェニル−4−イル スルファメートの結晶
0.32gを得た。 m.p.169−171℃1 H NMR(DMSO−d6):δ 1.29(9
H,s),7.40(4H,m),7.71(2H,
m),7.86(4H,m),8.07(4H,m),
10.24(1H,s). 元素分析(C23H24N2O4Sとして) 計算値(%):C,65.07;H,5.70;N,
6.60 分析値(%):C,65.16;H,5.91;N,
6.31 実施例104’−(ベンジルオキシカルバモイル)−ビフェニル−
4−イル スルファメート 4’−ヒドロキシビフェニル−4−カルボン酸ベンジル
オキシアミド(参考例13参照)1.0gのN,N−ジ
メチルホルムアミド10mL溶液に、60%水素化ナト
リウム(油性)138mgを加え1時間撹拌した。さら
に氷冷下スルファモイルクロリド724mgを加え、2
時間撹拌した。反応混合物を氷水に注ぎ、析出した結晶
をろ取し、水、メタノールで洗浄した。得られた結晶を
N,N−ジメチルホルムアミド−エタノール混合溶媒で
2回再結晶して、4’−(ベンジルオキシカルバモイ
ル)−ビフェニル−4−イル スルファメートの結晶3
4mgを得た。 m.p.212−214℃1 H NMR(DMSO−d6):δ 4.95(2
H,s),7.3−7.6(7H,m),7.81(6
H,m),8.05(2H,s),11.81(1H,
s). 元素分析(C20H18N2O5Sとして) 計算値(%):C,60.29;H,4.55;N,
7.03 分析値(%):C,60.56;H,4.68;N,
6.98 実施例114’−(ベンジルメチルカルバモイル)−ビフェニル−
4−イル スルファメート 4’−ヒドロキシビフェニル−4−カルボン酸 ベンジ
ルメチルアミド(参考例17参照)0.41gのN,N
−ジメチルホルムアミド15mL溶液に、60%水素化
ナトリウム(油性)62mgを加え1.5時間撹拌し
た。さらにスルファモイルクロリド300mgを加え、
室温で2時間撹拌した。反応混合物を氷水に注ぎ、酢酸
エチルで抽出し、4回水洗した。得られた酢酸エチル溶
液を無水硫酸ナトリウムで乾燥した後減圧下に乾固し
た。得られた残渣を薄層クロマトグラフィーで精製(展
開液:クロロホルム:アセトン=20:1)し、得られ
た結晶をシクロヘキサン−酢酸エチルの混合溶媒から再
結晶し、4’−(ベンジルメチルカルバモイル)−ビフ
ェニル−4−イル スルファメートの結晶170mgを
得た。 m.p.189−190℃1 H NMR(DMSO−d6):δ 2.90(3
H,s),4.4−4.8(2H,m),7.1−7.
5(7H,m),7.54(2H,m),7.77(4
H,m),8.05(2H,s). 元素分析(C21H20N2O4Sとして) 計算値(%):C,63.62;H,5.08;N,
7.07 分析値(%):C,63.57;H,5.12;N,
7.02 実施例124’−[(4−t−ブチルベンジル)メチルカルバモイ
ル]−ビフェニル−4−イル スルファメート 4’−ヒドロキシビフェニル−4−カルボン酸 (4−
t−ブチルベンジル)メチルアミド(参考例19参照)
0.44gのN,N−ジメチルホルムアミド10mL
溶液に、氷冷下60%水素化ナトリウム(油性)52m
gを加え30分間撹拌した。さらに氷冷下スルファモイ
ルクロリド277mgを加え、室温で2時間撹拌した。
反応混合物を氷水に注ぎ、酢酸エチルで抽出し、4回水
洗した。得られた酢酸エチル溶液を無水硫酸ナトリウム
で乾燥した後減圧下に乾固した。得られた残渣を薄層ク
ロマトグラフィーで精製(展開液:クロロホルム:アセ
トン=20:1)し、得られた結晶をシクロヘキサン−
酢酸エチルの混合溶媒から再結晶し、4’−[(4−t
−ブチルベンジル)メチルカルバモイル]−ビフェニル
−4−イル スルファメートの結晶0.21gを得た。 m.p.193−194℃1 H NMR(DMSO−d6):δ 2.63(9
H,s),4.23(3H,s),5.7−6.1(2
H,m),8.4−8.7(2H,m),8.73(4
H,m),8.89(2H,m),9.11(4H,
m),9.38(2H,s). 実施例134’−(ベンジルブチルカルバモイル)−ビフェニル−
4−イル スルファメート 4’−ヒドロキシビフェニル−4−カルボン酸 ベンジ
ルブチルアミド(参考例21参照)0.5gのN,N−
ジメチルホルムアミド10mL溶液に、60%水素化ナ
トリウム(油性) 64mgを加え30分間撹拌した。
さらにスルファモイルクロリド0.32gを加え、室温
で2時間撹拌した。反応混合物を氷水に注ぎ、酢酸エチ
ルで抽出し、4回水洗した。得られた酢酸エチル溶液を
無水硫酸ナトリウムで乾燥した後減圧下に乾固した。得
られた残渣を薄層クロマトグラフィーで精製(展開液:
クロロホルム:アセトン=20:1)し、得られた結晶
をシクロヘキサン−酢酸エチルの混合溶媒から再結晶
し、4’−(ベンジルブチルカルバモイル)−ビフェニ
ル−4−イル スルファメートの結晶110mgを得
た。 m.p.137−138℃1 H NMR(DMSO−d6):δ 0.6−1.7
(7H,m),3.19(2H,m),4.4−4.8
(2H,m),7.1−7.4(7H,m),7.51
(2H,m),7.77(4H,m),8.03(2
H,s). 元素分析(C24H26N2O4Sとして) 計算値(%):C,65.73;H,5.98;N,
6.39 分析値(%):C,65.59;H,6.02;N,
6.33 実施例144’−[(4−t−ブチルベンジル)オクチルカルバモ
イル]−ビフェニル−4−イル スルファメート 4’−ヒドロキシビフェニル−4−カルボン酸4−t−
ブチルベンジルオクチルアミド(参考例22参照)0.
47gのN,N−ジメチルホルムアミド10mL溶液
に、60%水素化ナトリウム(油性)48mgを加え1
時間撹拌した。さらにスルファモイルクロリド0.23
gを加え、室温で1時間撹拌した。反応混合物を氷水に
注ぎ、酢酸エチルで抽出し、4回水洗した。得られた酢
酸エチル溶液を無水硫酸ナトリウムで乾燥した後減圧下
に乾固した。得られた残渣を中圧カラムクロマトで精製
(溶出液:ヘキサン:酢酸エチル=1:1)し、得られ
た結晶をシクロヘキサン−酢酸エチル混合溶媒から再結
晶し、4’−[(4−t−ブチルベンジル)オクチルカ
ルバモイル]−ビフェニル−4−イル スルファメート
の結晶0.28gを得た。 m.p.114−117℃1 H NMR(DMSO−d6):δ 0.7−1.6
(24H,m),3.1−3.4(2H,m),4.4
−4.8(2H,m),7.1−7.4(6H,m),
7.50(2H,m),7.77(4H,m),8.0
8(2H,s). 元素分析(C32H42N2O4Sとして) 計算値(%):C,69.78;H,7.69;N,
5.09 分析値(%):C,69.90;H,7.71;N,
4.89 実施例154’−(スルファモイルオキシ)−ビフェニル−4−カ
ルボン酸 4’−ヒドロキシビフェニル−4−カルボン酸2.0g
のN,N−ジメチルホルムアミド60mL溶液に、60
%水素化ナトリウム(油性)0.78gを加え30分間
撹拌した。さらにスルファモイルクロリド4.8gを加
え、室温で一夜撹拌した。反応混合物を2Lの水に注
ぎ、析出した結晶をろ取し、水洗した。得られた結晶を
メタノールから再結晶し、4’−(スルファモイルオキ
シ)−ビフェニル−4−カルボン酸の結晶0.75gを
得た。 m.p.250℃以上1 H NMR(DMSO−d6):δ 7.40(2
H,m),7.82(4H,m),8.02(4H,
m),12.97(1H,br). 元素分析(C13H11NO5Sとして) 計算値(%):C,53.24;H,3.78;N,
4.78 分析値(%):C,53.49;H,3.91;N,
4.68 実施例164’−(1RS−ヒドロキシエチル)−ビフェニル−4
−イル スルファメート 4’−アセチルビフェニル−4−イル スルファメート
(実施例1参照)0.25gのメタノール20mL溶液
に、水素化ホウ素ナトリウム16mgを加え室温で1時
間撹拌し、さらに水素化ホウ素ナトリウム10mg加え
30分間撹拌した。反応混合物を減圧濃縮した。得られ
た残渣に、水を加え酢酸エチルで抽出した。得られた酢
酸エチル溶液を2回水洗し、無水硫酸ナトリウムで乾燥
した後減圧下に乾固した。得られた残渣を薄層クロマト
グラフィーで精製(展開液:クロロホルム:メタノール
=50:1)し、得られた結晶をシクロヘキサン−酢酸
エチル混合溶媒から再結晶し、4’−(IRS−ヒドロ
キシエチル)−ビフェニル−4−イル スルファメート
の結晶90mgを得た。 m.p.148−149℃1 H NMR(DMSO−d6):δ 1.34(3
H,d,J=6.5Hz),4.76(1H,m),
5.15(IH,d,J=4.2Hz),7.34(2
H,m),7.42(2H,m),7.59(2H,
m),7.71(2H,m),8.00(2H,s). 元素分析(C14H15NO4Sとして) 計算値(%):C,57.32;H,5.15;N,
4.77 分析値(%):C,57.34;H,5.20;N,
4.77 実施例174’−[2−(4−t−ブチルフェニル)−1RS−ヒ
ドロキシエチル]−ビフェニル−4−イル スルファメ
ート 4’−[2−(4−t−ブチルフェニル)−アセチル]
−ビフェニル−4−イルスルファメート(実施例2参
照)0.25gのメタノール20mL溶液に、水素化ホ
ウ素ナトリウム42mgを加え室温で1時間撹拌した。
反応混合物を減圧濃縮し、得られた残渣に水を加え酢酸
エチルで抽出した。得られた酢酸エチル溶液を2回水洗
し、無水硫酸ナトリウムで乾燥した後減圧下に乾固し
た。得られた残渣を中圧カラムクロマトで精製(溶出
液:ヘキサン:酢酸エチル=3:2)し、得られた結晶
をシクロヘキサン−酢酸エチル混合溶媒から再結晶し、
4’−[2−(4−t−ブチルフェニル)−1RS−ヒ
ドロキシエチル]−ビフェニル−4−イル スルファメ
ートの結晶0.16gを得た。 m.p.230℃付近分解1 H NMR(DMSO−d6):δ 1.26(9
H,s),2.87(2H,m),4.8(1H,
m),5.28(IH,d,J=4.9Hz),7.1
5(2H,m),7.27(2H,m),7.35(2
H,m),7.45(2H,m),7.62(2H,
m),7.74(2H,m),8.04(2H,s). 元素分析(C24H27NO4Sとして) 計算値(%):C,67.74,H,6.40;N,
3.29 分析値(%):C,67.81;H,6.51;N,
3.21 実施例18 4’−[2−(4−t−ブチルフェニル)−1RS−ヒ
ドロキシ−1−メチルエチル]−ビフェニル−4−イル
スルファメート 4’−[2−(4−t−ブチルフェニル)−1RS−ヒ
ドロキシ−1−メチルエチル]−ビフェニル−4−オー
ル(参考例23参照)0.5gのN,N−ジメチルホル
ムアミド10mL溶液に、60%水素化ナトリウム(油
性) 66mgを加え1時間撹拌した。さらにスルファ
モイルクロリド0.32gを加え、室温で2時間撹拌し
た。反応混合物を氷水に注ぎ、酢酸エチルで抽出し、4
回水洗した。得られた酢酸エチル溶液を無水硫酸ナトリ
ウムで乾燥した後減圧下に乾固した。得られた残渣を中
圧カラムクロマトで精製(溶出液:ヘキサン:酢酸エチ
ル=2:1〜1:1)し、得られた結晶をシクロヘキサ
ン−酢酸エチル混合溶媒から再結晶し、4’−[2−
(4−t−ブチルフェニル)−1RS−ヒドロキシ−1
−メチルエチル]−ビフェニル−4−イル スルファメ
ートの結晶30mgを得た。 m.p.158℃付近分解1 H NMR(DMSO−d6):δ 1.24(9
H,s),1.37(3H,s),2.92(2H,
s),5.05(1H,s),7.04(2H,m),
7.20(2H,m),7.35(2H,m),7.5
8(4H,m),7.74(2H,m),8.05(2
H,s). 元素分析(C25H29NO4Sとして) 計算値(%):C,68.31;H,6.65;N,
3.19 分析値(%):C,68.16;H,6.76;N,
3.04 参考例11−(4’−ヒドロキシビフェニル−4−イル)−エタ
ノン 4’−ヒドロキシビフェニル−4−カルボン酸3.4g
のテトラヒドロフラン7mL溶液に、氷冷下1.4Mメ
チルリチウムエーテル溶液を90mL滴下し2時間攪拌
し、さらに室温で一夜撹拌した。反応混合物に氷冷下塩
化アンモニウム水溶液を加え、1N塩酸でpH3に調整
し、酢酸エチルで抽出し2回水洗した。その後飽和炭酸
水素ナトリウム水溶液次いで塩水で洗浄し、無水硫酸ナ
トリウムで乾燥した後減圧下に乾固した。得られた残渣
をメタノールで洗浄して、1−(4’−ヒドロキシビフ
ェニル−4−イル)−エタノンの結晶1.01gを得
た。m.p.210−211℃1 H NMR(DMSO−d6):δ 2.57(3
H,s),6.86(2H,m),7.58(2H,
m),7.72(2H,m),7.96(2H,m),
9.69(2H,s). 元素分析(C14H12O2として) 計算値(%):C,79.22;H,5.70 分析値(%):C,79.15;H,5.72 参考例24’−メトキシメトキシビフェニル−4−カルボン酸 4’−ヒドロキシビフェニル−4−カルボン酸20gの
N,N−ジメチルホルムアミド300mL溶液に、60
%水素化ナトリウム(油性)4.5gを加え30分間撹
拌した。次に反応混合物にメトキシメチルクロリド9.
0gを加え、室温で一夜撹拌した。反応混合物を氷水に
注ぎ、析出した結晶をろ取した。得られた結晶を酢酸エ
チルに溶解し、水洗した。得られた酢酸エチル溶液を無
水硫酸ナトリウムで乾燥した後減圧下に乾固した。得ら
れた残渣を水150mL、ジオキサン300mLの混合
溶媒に溶解し、8N水酸化ナトリウム水溶液60mLを
加えて90℃で3時間加熱撹拌した。反応混合物を減圧
濃縮し、1N塩酸でpH5に調整し酢酸エチルで抽出し
た。不溶物をろ取後得られた酢酸エチル溶液を水洗し、
無水硫酸ナトリウムで乾燥し減圧下に乾固して、4’−
メトキシメトキシビフェニル−4−カルボン酸19.6
gを得た。1 H NMR(CDCl3):δ 3.53(3H,
s),5.25(2H,s),7.16(2H,m),
7.59(2H,m),7.68(2H,m),8.1
7(2H,m). 参考例34’−メトキシメトキシビフェニル−4−カルボン酸メ
チル(ピリジン−2−イル)アミド 4’−メトキシメトキシビフェニル−4−カルボン酸
(参考例2参照)3.0g、2−(メチルアミノ)ピリ
ジン1.1g、1−ヒドロキシベンゾトリアゾール一水
和物1.7gのN,N−ジメチルホルムアミド60mL
溶液に、塩酸1−エチル−3−(3−ジメチルアミノプ
ロピル)カルボジイミド2.2gを加え90℃で4時間
加熱撹拌した。反応混合物を氷水に注ぎ、酢酸エチルで
抽出し、4回水洗した。得られた酢酸エチル溶液を無水
硫酸ナトリウムで乾燥した後減圧下に乾固した。得られ
た残渣を中圧カラムクロマトで精製(溶出液:クロロホ
ルム:メタノール=100:1)し、4’−メトキシメ
トキシビフェニル−4−カルボン酸メチル(ピリジン−
2−イル)アミド2.9gを得た。1 H NMR(CDCl3):δ 3.51(3H,
s),3.62(3H,s),5.22(2H,s),
6.88(1H,m),7.08(3H,m),7.4
−7.6(7H,m),8.48(1H,m). 参考例42−(4−t−ブチルフェニル)−1−(4’−メトキ
シメトキシビフェニル−4−イル)−エタノン マグネシウム0.27gのエーテル10mL懸濁溶液に
4−t−ブチルベンジルブロミド2.58gのエーテル
5ml溶液を滴下し、アルゴン雰囲気下室温で30分間
攪拌した。得られた反応混合物を、ドライアイス−アセ
トン浴で冷却下、4’−メトキシメトキシビフェニル−
4−カルボン酸メチル(ピリジン−2−イル)アミド
(参考例3参照)2.9gのテトラヒドロフラン200
mL溶液に滴下し、3時間撹拌した。反応混合物を塩化
アンモニウム水溶液で希釈し、酢酸エチルで抽出した。
得られた酢酸エチル溶液を2回水洗し、無水硫酸ナトリ
ウムで乾燥した後減圧下に乾固した。得られた残渣を中
圧カラムクロマトで精製(溶出液:ヘキサン:酢酸エチ
ル=3:1)し、2−(4−t−ブチルフェニル)−1
−(4’−メトキシメトキシビフェニル−4−イル)−
エタノン0.36gを得た。1 H NMR(CDCl3):δ 1.32(9H,
s),3.53(3H,s),4.29(2H,s),
5.25(2H,s),7.15(2H,m),7.2
6(2H,m),7.38(2H,m),7.62(4
H,m),8.09(2H,m). 参考例5 2−(4−t−ブチルフェニル)−1−(4’−ヒドロ
キシビフェニル−4−イル)−エタノン 2−(4−t−ブチルフェニル)−1−(4’−メトキ
シメトキシビフェニル−4−イル)−エタノン(参考例
4参照)0.85gをメタノール10mL、酢酸エチル
30mLの混合溶媒に溶解し、4N塩酸(酢酸エチル溶
液)を3mL加え室温で一夜撹拌した。反応混合物を酢
酸エチルで希釈し、2回水洗した。得られた酢酸エチル
溶液を無水硫酸ナトリウムで乾燥した後減圧下に乾固
し、2−(4−t−ブチルフェニル)−1−(4’−ヒ
ドロキシビフェニル−4−イル)−エタノン0.78g
を得た。一部をメタノールから再結晶して得られた物
は、以下の物性を示した。 m.p.153−155℃1 H NMR(DMSO−d6):δ 1.26(9
H,s),4.33(2H,s),6.88(2H,
m),7.20(2H,m),7.33(2H,m),
7.59(2H,m),7.74(2H,m),8.0
7(2H,m),9.74(1H,s). 元素分析(C24H24O2として) 計算値(%):C,83.69;H,7.02 分析値(%):C,83.31;H,7.04 参考例61−(4’−ヒドロキシビフェニル−4−イル)−ペン
タン−1−オン 4’−ヒドロキシビフェニル−4−カルボン酸5.0g
のテトラヒドロフラン200mL溶液に、氷冷下、アル
ゴン雰囲気下1.6Mn−ブチルリチウム ヘキサン溶
液44mLを滴下し、4時間撹拌した。反応混合物に、
塩酸アンモニウム水溶液を加え、酢酸エチルで抽出し、
得られた酢酸エチル溶液を無水硫酸マグネシウムで乾燥
した後減圧下に乾固した。得られた残渣を中圧カラムク
ロマトで精製(溶出液:ヘキサン:酢酸エチル=5:
2)し、1−(4’−ヒドロキシビフェニル−4−イ
ル)−ペンタン−1−オン2.7gを得た。1 H NMR(CDCl3):δ 0.97(3H,
t,J=7.3Hz),1.42(2H,m),1.7
5(2H,m),2.99(2H,t,J=7.2H
z),5.06(1H,s),6.92(2H,m),
7.52(2H,m),7.63(2H,m),8.0
0(2H,m). 参考例71−(4’−ヒドロキシビフェニル−4−イル)−ヘプ
タン−1−オン 4’−ヒドロキシビフェニル−4−カルボン酸5.0g
のテトラヒドロフラン200mL溶液に、氷冷下、アル
ゴン雰囲気下25%n−ヘキシルリチウム ヘキサン溶
液35mLを滴下し、30分間撹拌した。反応混合物
に、塩酸アンモニウム水溶液を加え、酢酸エチルで抽出
し、希塩酸、水で洗浄した。得られた酢酸エチル溶液を
無水硫酸マグネシウムで乾燥した後減圧下に乾固した。
得られた残渣を中圧カラムクロマトで精製(溶出液:ヘ
キサン:酢酸エチル=5:1〜5:2)し、1−(4’
−ヒドロキシビフェニル−4−イル)−ヘプタン−1−
オン1.2gを得た。1 H NMR(CDCl3):δ 0.89(3H,
m),1.1−1.5(6H,m),1.78(2H,
m),2.99(2H,t,J=7.3Hz),5.1
(1H,br),6.94(2H,m),7.51(2
H,m),7.62(2H,m),8.01(2H,
m). 参考例84’−ヒドロキシビフェニル−4−カルボン酸エチルア
ミド 4’−ヒドロキシビフェニル−4−カルボン酸1.0g
のジオキサン10mL溶液に、1−ヒドロキシベンゾト
リアゾール一水和物0.67g、塩酸1−エチル−3−
(3−ジメチルアミノプロピル)カルボジイミド1.0
7gを加え、室温で1時間撹拌した。さらにエチルアミ
ン(70%水溶液)0.32gを加え、室温で18時間
撹拌した。反応混合物を氷水に注ぎ、酢酸エチルで抽出
し、水洗、さらに塩水で洗浄した。得られた酢酸エチル
溶液を無水硫酸マグネシウムで乾燥した後減圧下に乾固
した。得られた残渣を中圧カラムクロマトで精製(溶出
液:クロロホルム:メタノール=10:1)し、ジオキ
サン−ヘキサン混合溶媒から再結晶して4’−ヒドロキ
シビフェニル−4−カルボン酸エチルアミド0.74g
を得た。1 H NMR(CDCl3):δ1.28(3H,t,
J=7.3Hz),3.53(2H,m),6.92
(1H,m),6.95(2H,m),7.51(2
H,m),7.59(2H,m),7.81(3H,
m). 参考例94’−ヒドロキシビフェニル−4−カルボン酸オクチル
アミド 4’−ヒドロキシビフェニル−4−カルボン酸5.0g
のN,N−ジメチルホルムアミド50mL溶液に、氷冷
下1−ヒドロキシベンゾトリアゾール一水和物1.07
g、塩酸1−エチル−3−(3−ジメチルアミノプロピ
ル)カルボジイミド5.4gを加えた。さらにオクチル
アミン3.9gを加え、室温で6時間撹拌した。反応混
合物を氷水に注ぎ、酢酸エチルで抽出し、炭酸水素ナト
リウム水溶液で洗浄し、さらに水で洗浄した。得られた
酢酸エチル溶液を無水硫酸マグネシウムで乾燥した後減
圧下に乾固した。得られた残渣をメタノールから再結晶
し、4’−ヒドロキシビフェニル−4−カルボン酸オク
チルアミド3.14gを得た。1 H NMR(DMSO−d6):δ 0.86(3
H,t,J=6.9Hz),1.27(10H,m),
1.52(2H,m),3.2(2H,t,J=6.9
Hz),6.86(2H,m),7.56(2H,
m),7.66(2H,m),7.87(2H,m),
8.40(IH,d,J=5.6Hz),9.61(1
H,brs). 参考例104’−ヒドロキシビフェニル−4−カルボン酸2−フェ
ネチルアミド 4’−ヒドロキシビフェニル−4−カルボン酸1.3
g、2−フェネチルアミン0.74g、1−ヒドロキシ
ベンゾトリアゾール一水和物0.93gのN,N−ジメ
チルホルムアミド30mL溶液に、塩酸1−エチル−3
−(3−ジメチルアミノプロピル)カルボジイミド1.
17gを加え90℃で3時間加熱撹拌した。反応混合物
を氷水に注ぎ、酢酸エチルで抽出し、4回水洗した。得
られた酢酸エチル溶液を無水硫酸ナトリウムで乾燥した
後減圧下に乾固した。得られた残渣を酢酸エチルーメタ
ノール混合溶媒から再結晶して、4’−ヒドロキシビフ
ェニル−4−カルボン酸2−フェネチルアミド0.94
gを得た。 m.p.217−218℃1 H NMR(DMSO−d6):δ 2.85(2
H,t,J=7.9Hz),3.50(2H,m),
6.87(2H,m),7.1−7.4(5H,m),
7.56(2H,m),7.66(2H,m),7.8
6(2H,m),8.58(1H,m),9.66(1
H,s). 元素分析(C21H19NO2として) 計算値(%):C,79.47,H,6.03;N,
4.41 分析値(%):C,79.56;H,6.02;N,
4.48 参考例114’−ヒドロキシビフェニル−4−カルボン酸4−t−
ブチルベンジルアミド 4’−ヒドロキシビフェニル−4−カルボン酸0.8
g、4−t−ブチルベンジルアミン0.61g、1−ヒ
ドロキシベンゾトリアゾール一水和物0.57gのN,
N−ジメチルホルムアミド30mL溶液に、塩酸1−エ
チル−3−(3−ジメチルアミノプロピル)カルボジイ
ミド0.71gを加え90℃で3時間加熱撹拌した。反
応混合物を氷水に注ぎ、酢酸エチルで抽出し、4回水洗
した。得られた酢酸エチル溶液を無水硫酸ナトリウムで
乾燥した後減圧下に乾固した。得られた残渣を中圧カラ
ムクロマトで精製(溶出液:クロロホルム:メタノール
=100:1)し、4’−ヒドロキシビフェニル−4−
カルボン酸4−t−ブチルベンジルアミド1.0gを得
た。一部を酢酸エチルから再結晶して得られた物は、以
下の物性を示した。 m.p.180−181℃1 H NMR(DMSO−d6):δ 1.26(9
H,s),4.44(2H,d,J=6.0Hz),
6.87(2H,m),7.24(2H,m),7.3
5(2H,m),7.57(2H,m),7.68(2
H,m),7.93(2H,m),9.0(1H,
m),9.66(1H,s). 元素分析(C24H25NO2として) 計算値(%):C,80.19;H,7.01;N,
3.90 分析値(%):C,80.22;H,7.00;N,
3.91 参考例124’−ヒドロキシビフェニル−4−カルボン酸4−t−
ブチルフェニルアミド 4’−ヒドロキシビフェニル−4−カルボン酸2.0
g、4−t−ブチルアニリン1.4g、1−ヒドロキシ
ベンゾトリアゾール一水和物1.71gのN,N−ジメ
チルホルムアミド20mL溶液に、塩酸1−エチル−3
−(3−ジメチルアミノプロピル)カルボジイミド2.
15gを加え室温で3日間撹拌した。反応混合物を氷水
に注ぎ、酢酸エチルで抽出し、4回水洗した。得られた
酢酸エチル溶液を無水硫酸ナトリウムで乾燥した後減圧
下に乾固した。得られた残渣を中圧カラムクロマトで精
製(溶出液:ヘキサン:酢酸エチル=2:1〜1:1)
し、4’−ヒドロキシビフェニル−4−カルボン酸4−
t−ブチルフェニルアミド2.0gを得た。1 H NMR(DMSO−d6):δ 1.29(9
H,s),6.89(2H,m),7.37(2H,
m),7.60(2H,m),7.73(4H,m),
8.01(2H,m),9.69(1H,s),10.
18(2H,s). 参考例134’−ヒドロキシビフェニル−4−カルボン酸 ベンジ
ルオキシアミド 4’−ヒドロキシビフェニル−4−カルボン酸3.0
g、1−ヒドロキシベンゾトリアゾール一水和物1.0
7gのN,N−ジメチルホルムアミド45mL溶液に、
塩酸1−エチル−3−(3−ジメチルアミノプロピル)
カルボジイミド3.21gを加えた。さらに塩酸ベンジ
ルオキシアミン2.46g、トリエチルアミン9mLを
加え室温で一夜撹拌した。反応混合物を氷水に注ぎ、酢
酸エチルで抽出し、4回水洗した。得られた酢酸エチル
溶液を無水硫酸マグネシウムで乾燥した後減圧下に乾固
した。得られた残渣をエーテルで洗浄し、4’−ヒドロ
キシビフェニル−4−カルボン酸ベンジルオキシアミド
3.14gを得た。1 H NMR(DMSO−d6):δ 4.94(2
H,s),6.86(2H,m),7.3−7.5(5
H,m),7.56(2H,m),7.67(2H,
m),7.79(2H,m),9.64(1H,b
r). 参考例14ベンジル 4’−ベンジルオキシビフェニル−4−カル
ボキシレート 4’−ヒドロキシビフェニル−4−カルボン酸15gと
ベンジルブロミド18mLのN,N−ジメチルホルムア
ミド150mL溶液に、炭酸カリウム24gを加え室温
で1日間撹拌した。反応混合物を氷水1Lに注ぎ、析出
した結晶をろ取した。得られた結晶をクロロホルムに溶
解し水洗後、無水硫酸ナトリウムで乾燥した後減圧下に
乾固した。得られた残渣をメタノールで洗浄しベンジル
4’−ベンジルオキシビフェニル−4−カルボキシレ
ート18.8gを得た。1 H NMR(CDCl3):δ 5.13(2H,
s),5.39(2H,s),7.07(2H,m),
7.2−7.7(10H,m),7.60(4H,
m),8.12(2H,m). 参考例154’−ベンジルオキシビフェニル−4−カルボニル ク
ロリド ベンジル 4’−ベンジルオキシビフェニル−4−カル
ボキシレート(参考例14参照)18.8gを水20m
L、ジオキサン40mLの混合溶液に溶解し、8N水酸
化ナトリウム水溶液50mLを加え100℃で一夜加熱
撹拌した。反応混合物を減圧濃縮し、得られた残渣を水
に溶解し、1N塩酸でpH3に調整後、析出した結晶を
ろ取し、水洗、アセトン洗浄して粗結晶15gを得た。
得られた粗結晶2.58gに塩化チオニル10mLを加
え、2時間加熱還流した。反応混合物を減圧濃縮し、残
渣にクロロホルムを加え、析出している結晶をろ取して
4’−ベンジルオキシビフェニル−4−カルボニル ク
ロリド2.5gを得た。1 H NMR(DMSO−d6):δ 5.15(2
H,s),7.10(2H,m),7.2−7.6(5
H,m),7.7−7.8(4H,m),7.96(2
H,m). 参考例164’−ベンジルオキシビフェニル−4−カルボン酸 ベ
ンジルメチルアミド 4’−ベンジルオキシビフェニル−4−カルボニル ク
ロリド(参考例15参照)1g、トリエチルアミン0.
62gのテトラヒドロフラン30mL溶液に、N−メチ
ルベンジルアミン0.41gを加え、室温で一夜撹拌し
た。反応混合物を氷水に注ぎ、酢酸エチルで抽出した。
1N塩酸で洗浄、水洗後、得られた酢酸エチル溶液を無
水硫酸ナトリウムで乾燥した後減圧下に乾固した。得ら
れた残渣を中圧カラムクロマトで精製(溶出液:クロロ
ホルム)し、4’−ベンジルオキシビフェニル−4−カ
ルボン酸 ベンジルメチルアミド0.95gを得た。1 H NMR(DMSO−d6):δ 2.8−3.2
(3H,m),4.5−4.9(2H,m),5.13
(2H,s),7.07(2H,m),7.1−7.7
(16H,m). 参考例174’−ヒドロキシビフェニル−4−カルボン酸 ベンジ
ルメチルアミド 4’−ベンジルオキシビフェニル−4−カルボン酸 ベ
ンジルメチルアミド(参考例16参照)0.45gをメ
タノール50mL、ジオキサン50mLの混合溶液に溶
解し、10%パラジウム炭素(50%含水)150mg
を加えて、常圧で一夜接触還元した。反応混合物をろ取
し、減圧濃縮して、4’−ヒドロキシビフェニル−4−
カルボン酸 ベンジルメチルアミド0.41gを得た。1 H NMR(CDCl3):δ2.8−3.2(3
H,m),4.5−4.9(2H,m),6.85(2
H,m),7.1−7.7(12H,m).参考例184’−ベンジルオキシビフェニル−4−カルボン酸
(4−t−ブチルベンジル)メチルアミド 4’−ベンジルオキシビフェニル−4−カルボニル ク
ロリド(参考例15参照)1.2g、トリエチルアミン
0.41gのテトラヒドロフラン30mL溶液に、(4
−t−ブチルベンジル)メチルアミン0.72gのテト
ラヒドロフラン10mL溶液を滴下し、室温で3時間撹
拌した。反応混合物を氷水に注ぎ、酢酸エチルで抽出し
た。1N塩酸で洗浄し、得られた酢酸エチル溶液を無水
硫酸ナトリウムで乾燥した後減圧下に乾固した。得られ
た残渣を中圧カラムクロマトで精製(溶出液:クロロホ
ルム)し、4’−ベンジルオキシビフェニル−4−カル
ボン酸 (4−t−ブチルベンジル)メチルアミド1.
2gを得た。1 H NMR(CDCl3):δ 1.34(9H,
s),2.8−3.2(3H,m),4.4−4.8
(2H,m),5.12(2H,s),7.05(2
H,m),7.1−7.6(15H,m). 参考例194’−ヒドロキシビフェニル−4−カルボン酸 (4−
t−ブチルベンジル)メチルアミド 4’−ベンジルオキシビフェニル−4−カルボン酸
(4−t−ブチルベンジル)メチルアミド(参考例18
参照)0.6gをメタノール50mL、ジオキサン50
mLの混合溶液に溶解し、10%パラジウム炭素120
mgを加えて、常圧で5時間接触還元した。反応混合物
をろ取し、減圧濃縮して、4’−ヒドロキシビフェニル
−4−カルボン酸 (4−t−ブチルベンジル)メチル
アミド0.45gを得た。1 H NMR(DMSO−d6):δ 1.32(9
H,s),2.8−3.2(3H,m),4.4−4.
8(2H,m),6.82(2H,m),7.0−7.
4(3H,m),7.38(4H,m),7.48(4
H,m). 参考例204’−ベンジルオキシビフェニル−4−カルボン酸 ベ
ンジルブチルアミド 4’−ベンジルオキシビフェニル−4−カルボニル ク
ロリド(参考例15参照)1g、トリエチルアミン0.
62gのテトラヒドロフラン30mL懸濁溶液に、N−
ブチルベンジルアミン0.56g加え、室温で2時間撹
拌した。反応混合物を氷水に注ぎ、酢酸エチルで抽出し
た。1N塩酸で洗浄、水洗後、得られた酢酸エチル溶液
を無水硫酸ナトリウムで乾燥した後減圧下に乾固した。
得られた残渣を中圧カラムクロマトで精製(溶出液:ク
ロロホルム)し、4’−ベンジルオキシビフェニル−4
−カルボン酸 ベンジルブチルアミド1.02gを得
た。1 H NMR(CDCl3):δ 0.6−1.8(7
H,m),3.1−3.6(2H,m),4.5−4.
9(2H,m),5.14(2H,s),7.07(2
H,m),7.1−7.7(16H,m). 参考例214’−ヒドロキシビフェニル−4−カルボン酸 ベンジ
ルブチルアミド 4’−ベンジルオキシビフェニル−4−カルボン酸 ベ
ンジルブチルアミド(参考例20参照)0.6gをメタ
ノール30mL、ジオキサン30mLの混合溶液に溶解
し、10%パラジウム炭素0.15gを加えて、常圧で
一夜接触還元した。反応混合物をろ取し、減圧濃縮し
て、4’−ヒドロキシビフェニル−4−カルボン酸 ベ
ンジルブチルアミド0.5gを得た。1 H NMR(DMSO−d6):δ 0.6−1.7
(7H,m),3.22(2H,m),4.4−4.8
(2H,m),6.85(2H,m),7.1−7.5
(7H,m),7.53(2H,m),7.64(2
H,m),9.61(1H,s). 参考例224’−ヒドロキシビフェニル−4−カルボン酸4−t−
ブチルベンジルオクチルアミド 4’−ヒドロキシビフェニル−4−カルボン酸1.5
g、4−t−ブチルベンジルオクチルアミン1.9g、
1−ヒドロキシベンゾトリアゾール一水和物1.07g
のN,N−ジメチルホルムアミド20mL溶液に、塩酸
1−エチル−3−(3−ジメチルアミノプロピル)カル
ボジイミド1.34gを加え60℃で一夜加熱撹拌し
た。反応混合物を氷水に注ぎ、酢酸エチルで抽出し、4
回水洗した。得られた酢酸エチル溶液を無水硫酸ナトリ
ウムで乾燥した後減圧下に乾固した。得られた残渣を中
圧カラムクロマトで精製(溶出液:クロロホルム:メタ
ノール=100:1)し、4’−ヒドロキシビフェニル
−4−カルボン酸4−t−ブチルベンジルオクチルアミ
ド0.47gを得た。1 H NMR(DMSO−d6):δ 0.6−1.7
(24H,m),3.0−3.4(2H,m),4.4
−4.8(2H,m),6.85(2H,m),7.0
−7.5(6H,m),7.52(2H,m),7.6
3(2H,m),9.63(1H,s). 参考例234’−[2−(4−t−ブチルフェニル)−1RS−ヒ
ドロキシ−1−メチルエチル]−ビフェニル−4−オー
ル マグネシウム0.68mgのエーテル30mL懸濁溶液
に4−t−ブチルベンジルブロミド7.2gのエーテル
10ml溶液を滴下し、アルゴン雰囲気下室温で30分
間攪拌した。更に氷冷1−(4’−ヒドロキシビフェニ
ル−4−イル)−エタノン2.1gのテトラヒドロフラ
ン100ml溶液を滴下し、2時間撹拌した。反応混合
物を塩化アンモニウム水溶液で希釈し、酢酸エチルで抽
出、2回水洗した。得られた酢酸エチル溶液を無水硫酸
マグネシウムで乾燥した後減圧下に乾固し、得られた残
渣をヘキサンで洗浄し、メタノールから再結晶して、
4’−[2−(4−t−ブチルフェニル)−1RS−ヒ
ドロキシ−1−メチルエチル]−ビフェニル−4−オー
ルの結晶1.7gを得た。 m.p.158℃付近分解1 H NMR(DMSO−d6):δ 1.23(9
H,s),1.35(3H,s),2.92(2H,
s),4.99(1H,s),6.83(2H,m),
7.02(2H,m),7.19(2H,m),7.4
7(6H,m),9.51(1H,s). 元素分析(C25H28O2として) 計算値(%):C,83.29;H,7.83 分析値(%):C,82.87;H,7.99The present invention will be described below with reference to examples and reference examples.
The light will be described more specifically. Example 14'-acetylbiphenyl-4-yl sulfamate 1- (4'-hydroxybiphenyl-4-yl) -eta
Non (see Reference Example 1) 100 mg of N, N-dimethylphos
60% sodium hydride (oil)
G) 20 mg and stirred for 20 minutes. Further sulfa
110 mg of moyl chloride was added and stirred for 1.5 hours.
The reaction mixture was poured into ice water, extracted with ethyl acetate, and extracted four times with water.
I washed. The obtained ethyl acetate solution is dried over anhydrous sodium sulfate.
And dried under reduced pressure. The resulting residue is
Purification by chromatography (developing solution: chloroform: acetate)
Ton = 100: 16), and the obtained crystal was
Recrystallized from a mixed solvent of ethyl acetate and ethyl acetate to give 4'-acetyl
38 mg of crystals of rubiphenyl-4-yl sulfamate
I got m. p. 184.0-184.5 ° C1 1 H NMR (DMSO-d6): Δ 2.60 (3
H, s), 7.38 (2H, m), 7.84 (4H,
m), 8.03 (2H, m), 8.05 (2H, s). Elemental analysis (C14H13NO4S)) Calculated (%): C, 57.72; H, 4.50; N,
4.81 Analytical value (%): C, 57.61; H, 4.45; N,
4.74 Example 24 '-[2- (4-t-butylphenyl) -acetyl]
-Biphenyl-4-ylsulfamate 2- (4-t-butylphenyl) -1- (4'-hydro
Xibiphenyl-4-yl) -ethanone (See Reference Example 5)
See) 0.62 g of N, N-dimethylformamide 20 m
86 mg of 60% sodium hydride (oil-based) in the L solution
Was added and stirred for 30 minutes. Sulfamoyl chloride
0.415 g was added, and the mixture was stirred at room temperature for 2 hours. Reaction mixture
The mixture was poured into ice water, extracted with ethyl acetate, and washed four times with water.
Was. The obtained ethyl acetate solution is dried over anhydrous sodium sulfate.
After drying, the residue was dried under reduced pressure. The resulting residue is applied to a medium pressure column.
Purification by chromatography (eluent: hexane: ethyl acetate = 2:
1) Then, the obtained crystals were mixed with cyclohexane-ethyl acetate.
The crystals were recrystallized from the combined solvent to give 4 '-[2- (4-t-butylphenyl).
Enyl) -acetyl] -biphenyl-4-yl sulf
0.39 g of crystals of the halomate were obtained. m. p. 163-164 ° C1 1 H NMR (DMSO-d6): Δ 1.26 (9
H, s), 4.37 (2H, s), 7.21 (2H,
m), 7.37 (4H, m), 7.84 (4H, m),
8.12 (4H, m). Example 34 '-(n-pentanoyl) -biphenyl-4-yl
Sulfamate 1- (4'-hydroxybiphenyl-4-yl) -pen
Tan-1-one (see Reference Example 6) 0.5 g of N, N-di
60% hydrogenated sodium chloride in 5 mL of methylformamide
87 mg of oil (oil) was added and stirred for 1 hour. further
570 mg of sulfamoyl chloride was added under ice-cooling, and the mixture was added at room temperature.
For 18 hours. Pour the reaction mixture into ice water and add
Extracted with chill and washed 4 times with water. Ethyl acetate solution obtained
Is dried over anhydrous magnesium sulfate and then dried under reduced pressure.
Was. The resulting residue is purified by medium pressure silica gel chromatography (solvent
Effluent: chloroform: methanol = 99: 1)
The resulting crystals were recrystallized from methanol, and 4 '-(n-pen
Tanoyl) -biphenyl-4-yl sulfamate
0.37 g of crystals was obtained. m. p. 172-174 ° C1 1 H NMR (DMSO-d6): Δ 0.92 (3
H, t, J = 7 Hz), 1.38 (2H, m), 1.6
2 (2H, m), 3.05 (2H, t, J = 6 Hz),
7.40 (2H, m), 7.83 (4H, m), 8.0
5 (4H, m). Elemental analysis (C17H19NO4S
T) Calculated (%): C, 61.24; H, 5.74; N,
4.20 Analytical value (%): C, 61.38; H, 5.83; N,
4.29 Example 44 '-(n-heptanoyl) -biphenyl-4-yl
Sulfamate 1- (4'-hydroxybiphenyl-4-yl) -hep
Tan-1-one (see Reference Example 7) 0.6 g of N, N-di
60% hydrogenated sodium hydroxide in 10 mL of methylformamide
102 mg of lithium (oil) was added and stirred for 1 hour. Sa
And 0.5 g of sulfamoyl chloride under ice cooling.
Stirred at warm for 20 hours. Pour the reaction mixture into ice water and add acetic acid
Extracted with ethyl and washed 4 times with water. Ethyl acetate solution obtained
The solution was dried over anhydrous magnesium sulfate and then dried under reduced pressure.
Was. The resulting residue is purified by medium pressure silica gel chromatography (solvent
Effluent: chloroform: methanol = 99: 1) and 4 '
-(N-pentanoyl) -biphenyl-4-yl sulf
0.37 g of crystals of the famate were obtained. m. p. 172-174 ° C1 1 H NMR (DMSO-d6): Δ 0.87 (3
H, t, J: 7 Hz), 1.2-1.5 (6H, m),
1.62 (2H, m), 3.04 (2H, t, J = 7.
2Hz), 7.40 (2H, m), 7.84 (4H,
m), 8.07 (4H, m). Elemental analysis (C19H23NO4Calculated value (%): C, 63.13; H, 6.41; N,
3.88 Analytical value (%): C, 63.38; H, 6.56; N,
3.85 Example 54 '-(ethylcarbamoyl) -biphenyl-4-yl
Sulfamate Ethyl 4'-hydroxybiphenyl-4-carboxylate
Mid (see Reference Example 8) 0.3 g of N, N-dimethylform
In a 10 mL solution of muamide, add 60% sodium hydride (oil
G) 105 mg and stirred for 30 minutes. More sulph
Add 520 mg of amoyl chloride and stir at room temperature for 17 hours.
Stirred. Pour the reaction mixture into ice water and extract with ethyl acetate
And washed 4 times with water. The obtained ethyl acetate solution is subjected to sulfuric anhydride.
After drying with magnesium, it was dried under reduced pressure. Got
The residue was recrystallized from a hexane-ethyl acetate mixed solvent,
4 '-(ethylcarbamoyl) -biphenyl-4-yl
125 mg of crystals of the sulfamate were obtained.1 1 H NMR (DMSO-d6): Δ 1.13 (3
H, t, J = 7.1 Hz), 3.29 (2H, m),
7.37 (2H, m), 7.78 (4H, m), 7.9
4 (4H, m), 8.49 (3H, t, J = 5.9H
z). Elemental analysis (CFifteenH16N2O4Calculated value (%): C, 56.24; H, 5.03; N,
8.74 Analytical value (%): C, 56.22; H, 5.04; N,
8.67 Example 64 '-(octylcarbamoyl) -biphenyl-4-i
Le sulfamate Octyl 4'-hydroxybiphenyl-4-carboxylate
Amide (see Reference Example 9) 0.5 g of N, N-dimethylpho
Add a 60% sodium hydride (oil
G) 70 mg and stirred for 1 hour. Further under ice cooling
Add 445 mg of Famoyl chloride and leave at room temperature for 18 hours
Stirred. Pour the reaction mixture into ice water and extract with ethyl acetate
And washed 4 times with water. The obtained ethyl acetate solution is subjected to sulfuric anhydride.
After drying with magnesium, it was dried under reduced pressure. Got
The residue is purified by medium pressure column chromatography (eluent: chloroform).
M: methanol = 95: 5) and 4 '-(octylcal
Bamoyl) -biphenyl-4-yl sulfamate
0.34 g was obtained. m. p. 212-214 ° C1 1 H NMR (DMSO-d6): Δ 0.86 (3
H, t, J = 6.9 Hz), 1.27 (10H, m),
1.52 (2H, m), 3.25 (2H, t, J = 6.
9Hz), 7.40 (2H, m), 7.80 (4H,
m), 7.93 (2H, m), 8.04 (2H, s),
8.42 (1H, d, J = 5.4 Hz). Elemental analysis (C21H28N2O4Calculated value (%): C, 62.35; H, 6.98; N,
6.93 Analytical value (%): C, 62.08; H, 7.00; N,
6.89 Example 74 '-(2-phenethylcarbamoyl) -biphenyl-
4-yl sulfamate 4'-hydroxybiphenyl-4-carboxylic acid 2-fe
0.5 g of N, N-di-netylamide (see Reference Example 10)
60% hydrogenated sodium hydroxide in 10 mL of methylformamide
76 mg of lithium (oil) was added and stirred for 1 hour. further
Add 0.37 g of sulfamoyl chloride and leave for 2 hours at room temperature
While stirring. Pour the reaction mixture into ice water and extract with ethyl acetate.
Take out and wash 4 times. The obtained ethyl acetate solution is dried with anhydrous sulfur.
After drying over sodium acid, the mixture was dried under reduced pressure. Got
The residue was purified by thin-layer chromatography (developing solution: chloro
Form: acetone = 10: 1), and the obtained crystals are meta-
Recrystallized from phenol and 4 '-(2-phenethylcarbamo
Crystal of yl) -biphenyl-4-yl sulfamate
0.1 g was obtained. m. p. 250 ° C or higher1 1 H NMR (DMSO-d6): Δ 2.86 (2
H, t, J = 7.9 Hz), 3.50 (2H, m),
7.1-7.4 (7H, m), 7.80 (4H, m),
7.92 (2H, m), 8.08 (2H, s), 8.6
4 (1H, m). Elemental analysis (C21H20N2O4Calculated value (%): C, 63.62; H, 5.08; N,
7.07 Analytical value (%): C, 63.96; H, 5.10; N,
6.96 Example 84 '-(4-t-butylbenzylcarbamoyl) -biph
Phenyl-4-yl sulfamate 4'-hydroxybiphenyl-4-carboxylic acid 4-t-
0.5 g of butylbenzylamide (see Reference Example 11)
60% in N, N-dimethylformamide 10 mL solution
Add 66 mg of sodium hydride (oil) and stir for 1 hour
Was. Further, 0.32 g of sulfamoyl chloride was added,
Stirred at room temperature for 2 hours. Pour the reaction mixture into ice water and add acetic acid
Extracted with ethyl and washed 4 times with water. Ethyl acetate solution obtained
The solution was dried over anhydrous sodium sulfate and evaporated to dryness under reduced pressure.
Was. The obtained residue was purified by thin-layer chromatography (exhibition
Opening solution: chloroform: acetone = 10: 1)
The resulting crystals were recrystallized from ethyl acetate to give 4 '-(4-t-butyl).
Tylbenzylcarbamoyl) -biphenyl-4-yl
0.19 g of crystals of the sulfamate were obtained. m. p. 201-202 ° C1 1 H NMR (DMSO-d6): Δ 1.26 (9
H, s), 4.46 (2H, d, J = 5.9 Hz),
7.25 (2H, m), 7.37 (4H, m), 7.8
0 (4H, m), 7.86 (2H, m), 8.08 (2
H, s), 9.1 (1H, m). Elemental analysis (C24H26N2O4Calculated value (%): C, 65.73; H, 5.98; N,
6.39 Analytical value (%): C, 65.73, H, 5.96; N,
6.35 Example 94 '-(4-t-butylphenylcarbamoyl) -biph
Phenyl-4-yl sulfamate 4'-hydroxybiphenyl-4-carboxylic acid 4-t-
0.5 g of butylphenylamide (see Reference Example 12)
60% in N, N-dimethylformamide 10 mL solution
Add 68 mg of sodium hydride (oil) and stir for 1.5 hours
Stirred. Further, 0.32 g of sulfamoyl chloride was added.
And stirred at room temperature for 2 hours. Pour the reaction mixture into ice water,
Extracted with ethyl acetate and washed 4 times with water. The obtained ethyl acetate
Solution is dried over anhydrous sodium sulfate and then dried under reduced pressure.
did. The residue obtained is purified by medium pressure column chromatography (elution
Liquid: hexane: ethyl acetate = 3: 1 to 2: 1)
The crystals were recovered from a mixed solvent of cyclohexane and ethyl acetate.
Crystallized, 4 '-(4-t-butylphenylcarbamoy
) -Biphenyl-4-yl sulfamate crystals
0.32 g was obtained. m. p. 169-171 ° C1 1 H NMR (DMSO-d6): Δ 1.29 (9
H, s), 7.40 (4H, m), 7.71 (2H,
m), 7.86 (4H, m), 8.07 (4H, m),
10.24 (1H, s). Elemental analysis (C23H24N2O4Calculated value (%): C, 65.07; H, 5.70; N,
6.60 Analytical value (%): C, 65.16; H, 5.91; N,
6.31 Example 104 '-(benzyloxycarbamoyl) -biphenyl-
4-yl sulfamate Benzyl 4'-hydroxybiphenyl-4-carboxylate
Oxyamide (see Reference Example 13) 1.0 g of N, N-di
60% hydrogenated sodium hydroxide in 10 mL of methylformamide
138 mg of lithium (oil) was added and stirred for 1 hour. Further
Was added with 724 mg of sulfamoyl chloride under ice cooling.
Stirred for hours. The reaction mixture was poured into ice water and the precipitated crystals
Was collected by filtration and washed with water and methanol. The obtained crystal
N, N-dimethylformamide-ethanol mixed solvent
Recrystallization twice, 4 '-(benzyloxycarbamoy
) -Biphenyl-4-yl sulfamate crystal 3
4 mg were obtained. m. p. 212-214 ° C1 1 H NMR (DMSO-d6): Δ 4.95 (2
H, s), 7.3-7.6 (7H, m), 7.81 (6
H, m), 8.05 (2H, s), 11.81 (1H,
s). Elemental analysis (C20H18N2O5Calculated as (S): C, 60.29; H, 4.55; N,
7.03 Analytical value (%): C, 60.56; H, 4.68; N,
6.98 Example 114 '-(benzylmethylcarbamoyl) -biphenyl-
4-yl sulfamate 4'-hydroxybiphenyl-4-carboxylic acid benzyl
0.41 g of N, N
-60% hydrogenation in 15 mL dimethylformamide solution
Add 62 mg of sodium (oil) and stir for 1.5 hours
Was. Further, add 300 mg of sulfamoyl chloride,
Stirred at room temperature for 2 hours. Pour the reaction mixture into ice water and add acetic acid
Extracted with ethyl and washed 4 times with water. Ethyl acetate solution obtained
The solution was dried over anhydrous sodium sulfate and evaporated to dryness under reduced pressure.
Was. The obtained residue was purified by thin-layer chromatography (exhibition
Opening solution: chloroform: acetone = 20: 1)
The crystals were recovered from a mixed solvent of cyclohexane and ethyl acetate.
Crystallized, 4 '-(benzylmethylcarbamoyl) -biph
170 mg of crystals of enyl-4-yl sulfamate
Obtained. m. p. 189-190 ° C1 1 H NMR (DMSO-d6): Δ 2.90 (3
H, s), 4.4-4.8 (2H, m), 7.1-7.
5 (7H, m), 7.54 (2H, m), 7.77 (4
H, m), 8.05 (2H, s). Elemental analysis (C21H20N2O4Calculated value (%): C, 63.62; H, 5.08; N,
7.07 Analytical value (%): C, 63.57; H, 5.12; N,
7.02 Example 124 '-[(4-t-butylbenzyl) methylcarbamoy
Ru] -biphenyl-4-yl sulfamate 4'-hydroxybiphenyl-4-carboxylic acid (4-
t-butylbenzyl) methylamide (see Reference Example 19)
0.44 g of N, N-dimethylformamide 10 mL
To the solution, 52% of 60% sodium hydride (oil) under ice cooling
g was added and stirred for 30 minutes. Sulfamoi under ice-cooling
277 mg of luchloride was added, and the mixture was stirred at room temperature for 2 hours.
The reaction mixture was poured into ice water, extracted with ethyl acetate, and extracted four times with water.
I washed. The obtained ethyl acetate solution is dried over anhydrous sodium sulfate.
And dried under reduced pressure. The resulting residue is
Purification by chromatography (developing solution: chloroform: acetate)
Ton = 20: 1), and the obtained crystal was subjected to cyclohexane-
The crystals were recrystallized from a mixed solvent of ethyl acetate, and 4 '-[(4-t
-Butylbenzyl) methylcarbamoyl] -biphenyl
0.21 g of crystals of -4-yl sulfamate was obtained. m. p. 193-194 ° C1 1 H NMR (DMSO-d6): Δ 2.63 (9
H, s), 4.23 (3H, s), 5.7-6.1 (2
H, m), 8.4-8.7 (2H, m), 8.73 (4
H, m), 8.89 (2H, m), 9.11 (4H,
m), 9.38 (2H, s). Example 134 '-(benzylbutylcarbamoyl) -biphenyl-
4-yl sulfamate 4'-hydroxybiphenyl-4-carboxylic acid benzyl
Rubutylamide (see Reference Example 21) 0.5 g of N, N-
To a 10 mL solution of dimethylformamide, add 60% hydrogenated
64 mg of thorium (oil) was added and stirred for 30 minutes.
Further, 0.32 g of sulfamoyl chloride was added,
For 2 hours. Pour the reaction mixture into ice water and add ethyl acetate.
And washed four times with water. Ethyl acetate solution obtained
After drying over anhydrous sodium sulfate, it was evaporated to dryness under reduced pressure. Profit
The obtained residue was purified by thin-layer chromatography (developing solution:
Chloroform: acetone = 20: 1) and the obtained crystals
Was recrystallized from a mixed solvent of cyclohexane and ethyl acetate.
And 4 '-(benzylbutylcarbamoyl) -biphenyl
110 mg of crystals of ru-4-yl sulfamate were obtained.
Was. m. p. 137-138 ° C1 1 H NMR (DMSO-d6): Δ 0.6-1.7
(7H, m), 3.19 (2H, m), 4.4-4.8
(2H, m), 7.1-7.4 (7H, m), 7.51
(2H, m), 7.77 (4H, m), 8.03 (2
H, s). Elemental analysis (C24H26N2O4Calculated value (%): C, 65.73; H, 5.98; N,
6.39 Analytical value (%): C, 65.59; H, 6.02; N,
6.33 Example 144 '-[(4-t-butylbenzyl) octylcarbamo
Yl] -biphenyl-4-yl sulfamate 4'-hydroxybiphenyl-4-carboxylic acid 4-t-
Butylbenzyloctylamide (see Reference Example 22)
47 g of N, N-dimethylformamide 10 mL solution
, Add 48 mg of 60% sodium hydride (oil-based) to
Stirred for hours. Furthermore, sulfamoyl chloride 0.23
g was added and stirred at room temperature for 1 hour. Reaction mixture in ice water
The mixture was poured, extracted with ethyl acetate, and washed four times with water. Vinegar obtained
The ethyl acetate solution was dried over anhydrous sodium sulfate, and then dried under reduced pressure.
To dryness. The obtained residue is purified by medium pressure column chromatography.
(Eluent: hexane: ethyl acetate = 1: 1).
Crystals were reconstituted from a mixed solvent of cyclohexane and ethyl acetate.
4 '-[(4-t-butylbenzyl) octylka
Rubamoyl] -biphenyl-4-yl sulfamate
0.28 g of crystal was obtained. m. p. 114-117 ° C1 1 H NMR (DMSO-d6): Δ 0.7-1.6
(24H, m), 3.1-3.4 (2H, m), 4.4
-4.8 (2H, m), 7.1-7.4 (6H, m),
7.50 (2H, m), 7.77 (4H, m), 8.0
8 (2H, s). Elemental analysis (C32H42N2O4Calculated value (%): C, 69.78; H, 7.69; N,
5.09 Analytical value (%): C, 69.90; H, 7.71; N,
4.89 Example 154 '-(sulfamoyloxy) -biphenyl-4-ca
Rubonic acid 2.0 g of 4'-hydroxybiphenyl-4-carboxylic acid
Of N, N-dimethylformamide in 60 mL
% Sodium hydride (oil-based) 0.78 g for 30 minutes
Stirred. Further, 4.8 g of sulfamoyl chloride was added.
And stirred at room temperature overnight. Pour the reaction mixture into 2 L of water
The precipitated crystals were collected by filtration and washed with water. The obtained crystal
Recrystallized from methanol, 4 '-(sulfamoyloxy
0.75 g of crystals of b) -biphenyl-4-carboxylic acid
Obtained. m. p. 250 ° C or higher1 1 H NMR (DMSO-d6): Δ 7.40 (2
H, m), 7.82 (4H, m), 8.02 (4H,
m), 12.97 (1H, br). Elemental analysis (C13H11NO5Calculated value (%): C, 53.24; H, 3.78; N,
4.78 Analytical value (%): C, 53.49; H, 3.91; N,
4.68 Example 164 '-(1RS-hydroxyethyl) -biphenyl-4
-Ill sulfamate 4'-acetylbiphenyl-4-yl sulfamate
(See Example 1) A solution of 0.25 g of methanol in 20 mL
16 mg of sodium borohydride
And then add 10 mg of sodium borohydride
Stir for 30 minutes. The reaction mixture was concentrated under reduced pressure. Obtained
Water was added to the residue, which was extracted with ethyl acetate. Vinegar obtained
Wash the ethyl acid solution twice with water and dry over anhydrous sodium sulfate
After that, the mixture was dried under reduced pressure. The obtained residue is subjected to thin layer chromatography.
Purified by chromatography (developing solution: chloroform: methanol)
= 50: 1), and the obtained crystals were subjected to cyclohexane-acetic acid.
Recrystallized from a mixed solvent of ethyl, and 4 '-(IRS-hydro
(Xyethyl) -biphenyl-4-yl sulfamate
90 mg of crystals were obtained. m. p. 148-149 ° C1 1 H NMR (DMSO-d6): Δ 1.34 (3
H, d, J = 6.5 Hz), 4.76 (1H, m),
5.15 (IH, d, J = 4.2 Hz), 7.34 (2
H, m), 7.42 (2H, m), 7.59 (2H,
m), 7.71 (2H, m), 8.00 (2H, s). Elemental analysis (C14HFifteenNO4Calculated value (%): C, 57.32; H, 5.15; N,
4.77 Analytical value (%): C, 57.34; H, 5.20; N,
4.77 Example 174 '-[2- (4-t-butylphenyl) -1RS-H
Droxyethyl] -biphenyl-4-yl sulfame
To 4 '-[2- (4-t-butylphenyl) -acetyl]
-Biphenyl-4-ylsulfamate (see Example 2)
See) Hydrogenated hydrogen in a solution of 0.25 g of methanol in 20 mL.
42 mg of sodium iodide was added, and the mixture was stirred at room temperature for 1 hour.
The reaction mixture was concentrated under reduced pressure, water was added to the obtained residue, and acetic acid was added.
Extracted with ethyl. Wash the obtained ethyl acetate solution twice with water
And dried over anhydrous sodium sulfate.
Was. The residue obtained is purified by medium pressure column chromatography (elution
Liquid: hexane: ethyl acetate = 3: 2), and the obtained crystals
Is recrystallized from a mixed solvent of cyclohexane-ethyl acetate,
4 '-[2- (4-t-butylphenyl) -1RS-h
Droxyethyl] -biphenyl-4-yl sulfame
There were obtained 0.16 g of crystals of a salt. m. p. Decomposed around 230 ° C1 1 H NMR (DMSO-d6): Δ 1.26 (9
H, s), 2.87 (2H, m), 4.8 (1H,
m), 5.28 (IH, d, J = 4.9 Hz), 7.1
5 (2H, m), 7.27 (2H, m), 7.35 (2
H, m), 7.45 (2H, m), 7.62 (2H,
m), 7.74 (2H, m), 8.04 (2H, s). Elemental analysis (C24H27NO4Calculated value (%): C, 67.74, H, 6.40; N,
3.29 Analytical value (%): C, 67.81; H, 6.51; N,
3.21 Example 18 4 '-[2- (4-t-butylphenyl) -1RS-h
Droxy-1-methyleTyl] -biphenyl-4-yl
Sulfamate 4 '-[2- (4-t-butylphenyl) -1RS-h
Droxy-1-methylethyl] -biphenyl-4-o
(See Reference Example 23) 0.5 g of N, N-dimethylform
In a 10 mL solution of muamide, add 60% sodium hydride (oil
66 mg) and stirred for 1 hour. Further sulfa
Add 0.32 g of moyl chloride and stir at room temperature for 2 hours.
Was. The reaction mixture was poured into ice water, extracted with ethyl acetate,
Washed twice. The obtained ethyl acetate solution is dried over anhydrous sodium sulfate.
And dried under reduced pressure. The resulting residue is medium
Purification by pressure column chromatography (eluent: hexane: ethyl acetate
= 2: 1 to 1: 1), and the resulting crystals are
Recrystallized from a mixed solvent of ethyl acetate and ethyl acetate to give 4 '-[2-
(4-t-butylphenyl) -1RS-hydroxy-1
-Methylethyl] -biphenyl-4-yl sulfame
30 mg of crystals were obtained. m. p. Decomposes around 158 ° C1 1 H NMR (DMSO-d6): Δ 1.24 (9
H, s), 1.37 (3H, s), 2.92 (2H,
s), 5.05 (1H, s), 7.04 (2H, m),
7.20 (2H, m), 7.35 (2H, m), 7.5
8 (4H, m), 7.74 (2H, m), 8.05 (2
H, s). Elemental analysis (C25H29NO4Calculated value (%): C, 68.31; H, 6.65; N,
3.19 Analytical value (%): C, 68.16; H, 6.76; N,
3.04 Reference Example 11- (4'-hydroxybiphenyl-4-yl) -eta
Non 3.4 g of 4'-hydroxybiphenyl-4-carboxylic acid
To a 7 mL solution of tetrahydrofuran under ice cooling.
90 mL of chilled lithium ether solution is added dropwise and stirred for 2 hours
Then, the mixture was further stirred at room temperature overnight. Add salt under ice cooling to the reaction mixture
Add ammonium chloride aqueous solution and adjust to pH 3 with 1N hydrochloric acid
Then, the mixture was extracted with ethyl acetate and washed twice with water. Then saturated carbonic acid
Wash with aqueous sodium hydrogen solution and then with brine, and dry over anhydrous sodium sulfate.
After drying with thorium, it was evaporated to dryness under reduced pressure. The residue obtained
Is washed with methanol to give 1- (4'-hydroxybifu
1.01 g of crystals of phenyl-4-yl) -ethanone were obtained.
Was. m. p. 210-211 ° C1 1 H NMR (DMSO-d6): Δ 2.57 (3
H, s), 6.86 (2H, m), 7.58 (2H,
m), 7.72 (2H, m), 7.96 (2H, m),
9.69 (2H, s). Elemental analysis (C14H12O2Calculated value (%): C, 79.22; H, 5.70 Analytical value (%): C, 79.15; H, 5.72 Reference example 24'-methoxymethoxybiphenyl-4-carboxylic acid 20 g of 4'-hydroxybiphenyl-4-carboxylic acid
N, N-dimethylformamide 300mL solution, 60
4.5% sodium hydride (oil-based) and stirred for 30 minutes
Stirred. Next, methoxymethyl chloride was added to the reaction mixture.
0 g was added and the mixture was stirred at room temperature overnight. Reaction mixture in ice water
Poured and the precipitated crystals were collected by filtration. The obtained crystals are washed with acetic acid.
Dissolved in chill and washed with water. Ethyl acetate solution obtained
After drying with sodium hydrogen sulfate, the mixture was dried under reduced pressure. Get
The residue was mixed with 150 mL of water and 300 mL of dioxane.
Dissolve in the solvent and add 60 mL of 8N aqueous sodium hydroxide
In addition, the mixture was heated and stirred at 90 ° C. for 3 hours. Vacuum the reaction mixture
Concentrate, adjust to pH 5 with 1N hydrochloric acid, extract with ethyl acetate
Was. The ethyl acetate solution obtained after filtering off insolubles was washed with water,
After drying over anhydrous sodium sulfate and drying under reduced pressure, 4'-
Methoxymethoxybiphenyl-4-carboxylic acid 19.6
g was obtained.1 1 H NMR (CDCl 3): δ 3.53 (3H,
s), 5.25 (2H, s), 7.16 (2H, m),
7.59 (2H, m), 7.68 (2H, m), 8.1
7 (2H, m). Reference Example 34'-methoxymethoxybiphenyl-4-carboxylic acid
Tyl (pyridin-2-yl) amide 4'-methoxymethoxybiphenyl-4-carboxylic acid
(See Reference Example 2) 3.0 g, 2- (methylamino) pyri
Gin 1.1 g, 1-hydroxybenzotriazole monohydrate
1.7 g of N, N-dimethylformamide of 1.7 g of the hydrate
To the solution was added 1-ethyl-3- (3-dimethylaminohydrochloride).
(Ropyl) 2.2 g of carbodiimide was added and the mixture was heated at 90 ° C. for 4 hours.
The mixture was heated and stirred. Pour the reaction mixture into ice water and add ethyl acetate
Extracted and washed 4 times with water. Ethyl acetate solution obtained is anhydrous
After drying over sodium sulfate, it was evaporated to dryness under reduced pressure. Obtained
The residue was purified by medium pressure column chromatography (eluent: chloropho
Lum: methanol = 100: 1) and 4'-methoxymeth
Methyl toxibiphenyl-4-carboxylate (pyridine-
2.9 g of 2-yl) amide were obtained.1 H NMR (CDCl3): Δ 3.51 (3H,
s), 3.62 (3H, s), 5.22 (2H, s),
6.88 (1H, m), 7.08 (3H, m), 7.4
-7.6 (7H, m), 8.48 (1H, m). Reference example 42- (4-t-butylphenyl) -1- (4'-methoxy
Cimethoxybiphenyl-4-yl) -ethanone To a suspension solution of 0.27 g of magnesium in 10 mL of ether
2.58 g of 4-t-butylbenzyl bromide in ether
5 ml of the solution is added dropwise, and at room temperature under argon atmosphere for 30 minutes
Stirred. The obtained reaction mixture is mixed with dry ice-acetone.
4'-methoxymethoxybiphenyl-
Methyl 4-carboxylate (pyridin-2-yl) amide
(See Reference Example 3) 2.9 g of tetrahydrofuran 200
The solution was added dropwise to the mL solution and stirred for 3 hours. Chloride the reaction mixture
Dilute with aqueous ammonium and extract with ethyl acetate.
The obtained ethyl acetate solution was washed twice with water and dried over anhydrous sodium sulfate.
And dried under reduced pressure. The resulting residue is medium
Purification by pressure column chromatography (eluent: hexane: ethyl acetate
= 3: 1) and 2- (4-t-butylphenyl) -1
-(4'-methoxymethoxybiphenyl-4-yl)-
0.36 g of ethanone was obtained.1 H NMR (CDCl3): Δ 1.32 (9H,
s), 3.53 (3H, s), 4.29 (2H, s),
5.25 (2H, s), 7.15 (2H, m), 7.2
6 (2H, m), 7.38 (2H, m), 7.62 (4
H, m), 8.09 (2H, m). Reference Example 5 2- (4-t-butylphenyl) -1- (4'-hydro
Xibiphenyl-4-iLe)-Ethanone 2- (4-t-butylphenyl) -1- (4'-methoxy)
Cimethoxybiphenyl-4-yl) -ethanone (Reference example)
4) 0.85 g in methanol 10 mL, ethyl acetate
Dissolve in 30 mL of the mixed solvent, and add 4N hydrochloric acid (ethyl acetate
3 mL) and stirred overnight at room temperature. Vinegar reaction mixture
The mixture was diluted with ethyl acid and washed twice with water. Ethyl acetate obtained
The solution was dried over anhydrous sodium sulfate and then dried under reduced pressure.
And 2- (4-t-butylphenyl) -1- (4'-h
0.78 g of droxybiphenyl-4-yl) -ethanone
I got A product obtained by recrystallizing part of methanol
Showed the following physical properties. m. p. 153-155 ° C1 1 H NMR (DMSO-d6): Δ 1.26 (9
H, s), 4.33 (2H, s), 6.88 (2H,
m), 7.20 (2H, m), 7.33 (2H, m),
7.59 (2H, m), 7.74 (2H, m), 8.0
7 (2H, m), 9.74 (1H, s). Elemental analysis (C24H24O2Calculated value (%): C, 83.69; H, 7.02 Analysis value (%): C, 83.31; H, 7.04 Reference example 61- (4'-hydroxybiphenyl-4-yl) -pen
Tan-1-one 4'-hydroxybiphenyl-4-carboxylic acid 5.0 g
Was added to a 200 mL solution of
1.6Mn-butyllithium hexane solution in gon atmosphere
44 mL of the liquid was added dropwise and stirred for 4 hours. In the reaction mixture,
An ammonium chloride aqueous solution was added, and the mixture was extracted with ethyl acetate.
The obtained ethyl acetate solution is dried over anhydrous magnesium sulfate.
After that, the mixture was dried under reduced pressure. The residue obtained is filtered with a medium pressure column.
Purification by chromatography (eluent: hexane: ethyl acetate = 5:
2) and 1- (4'-hydroxybiphenyl-4-i
2.7 g of l) -pentan-1-one were obtained.1 H NMR (CDCl3): Δ 0.97 (3H,
t, J = 7.3 Hz), 1.42 (2H, m), 1.7
5 (2H, m), 2.99 (2H, t, J = 7.2H
z), 5.06 (1H, s), 6.92 (2H, m),
7.52 (2H, m), 7.63 (2H, m), 8.0
0 (2H, m). Reference Example 71- (4'-hydroxybiphenyl-4-yl) -hep
Tan-1-one 4'-hydroxybiphenyl-4-carboxylic acid 5.0 g
Was added to a 200 mL solution of
25% n-hexyllithium hexane solution under gon atmosphere
35 mL of the liquid was added dropwise and stirred for 30 minutes. Reaction mixture
To the solution, and extracted with ethyl acetate
And washed with diluted hydrochloric acid and water. Ethyl acetate solution obtained
After drying over anhydrous magnesium sulfate, it was evaporated to dryness under reduced pressure.
The residue obtained is purified by medium pressure column chromatography (eluate:
Xan: ethyl acetate = 5: 1 to 5: 2) and 1- (4 '
-Hydroxybiphenyl-4-yl) -heptane-1-
1.2 g of on was obtained.1 H NMR (CDCl3): Δ 0.89 (3H,
m), 1.1-1.5 (6H, m), 1.78 (2H,
m), 2.99 (2H, t, J = 7.3 Hz), 5.1
(1H, br), 6.94 (2H, m), 7.51 (2
H, m), 7.62 (2H, m), 8.01 (2H,
m). Reference Example 8Ethyl 4'-hydroxybiphenyl-4-carboxylate
Mid 1.0 g of 4'-hydroxybiphenyl-4-carboxylic acid
To a 10 mL solution of dioxane in 1-hydroxybenzoto
0.67 g of riazole monohydrate, 1-ethyl-3-hydrochloric acid
(3-dimethylaminopropyl) carbodiimide 1.0
7 g was added, and the mixture was stirred at room temperature for 1 hour. More ethylami
(70% aqueous solution) at room temperature for 18 hours
Stirred. Pour the reaction mixture into ice water and extract with ethyl acetate
Then, it was washed with water and further with brine. Ethyl acetate obtained
The solution was dried over anhydrous magnesium sulfate and then dried under reduced pressure.
did. The residue obtained is purified by medium pressure column chromatography (elution
Liquid: chloroform: methanol = 10: 1)
Recrystallization from a mixed solvent of sun-hexane gives 4'-hydroxy
0.74 g of sibiphenyl-4-carboxylic acid ethylamide
I got1 H NMR (CDCl3): Δ 1.28 (3H, t,
J = 7.3 Hz), 3.53 (2H, m), 6.92
(1H, m), 6.95 (2H, m), 7.51 (2
H, m), 7.59 (2H, m), 7.81 (3H,
m). Reference Example 9Octyl 4'-hydroxybiphenyl-4-carboxylate
Amide 4'-hydroxybiphenyl-4-carboxylic acid 5.0 g
In a 50 mL solution of N, N-dimethylformamide
Lower 1-hydroxybenzotriazole monohydrate 1.07
g, 1-ethyl-3- (3-dimethylaminopropyl hydrochloride)
F) 5.4 g of carbodiimide was added. Octyl
Amine (3.9 g) was added, and the mixture was stirred at room temperature for 6 hours. Reaction mixture
The mixture was poured into ice water, extracted with ethyl acetate,
It was washed with an aqueous solution of lithium and further washed with water. Got
Reduce the ethyl acetate solution after drying over anhydrous magnesium sulfate.
Dry under pressure. The obtained residue is recrystallized from methanol
And 4'-hydroxybiphenyl-4-carboxylic acid octane
3.14 g of tylamide were obtained.1 1 H NMR (DMSO-d6): Δ 0.86 (3
H, t, J = 6.9 Hz), 1.27 (10H, m),
1.52 (2H, m), 3.2 (2H, t, J = 6.9)
Hz), 6.86 (2H, m), 7.56 (2H,
m), 7.66 (2H, m), 7.87 (2H, m),
8.40 (IH, d, J = 5.6 Hz), 9.61 (1
H, brs). Reference example 104'-hydroxybiphenyl-4-carboxylic acid 2-fe
Netylamide 4'-hydroxybiphenyl-4-carboxylic acid 1.3
g, 2-phenethylamine 0.74 g, 1-hydroxy
Benzotriazole monohydrate 0.93 g of N, N-dimethyl
To a 30 mL solution of tilformamide was added 1-ethyl-3 hydrochloric acid.
-(3-dimethylaminopropyl) carbodiimide
17 g was added and the mixture was heated and stirred at 90 ° C. for 3 hours. Reaction mixture
Was poured into ice water, extracted with ethyl acetate, and washed four times with water. Profit
Ethyl acetate solution was dried over anhydrous sodium sulfate
Thereafter, it was dried under reduced pressure. The obtained residue is ethyl acetate-meta
And recrystallized from a mixed solvent of 4'-hydroxybiph.
Phenyl-4-carboxylic acid 2-phenethylamide 0.94
g was obtained. m. p. 217-218 ° C1 1 H NMR (DMSO-d6): Δ 2.85 (2
H, t, J = 7.9 Hz), 3.50 (2H, m),
6.87 (2H, m), 7.1-7.4 (5H, m),
7.56 (2H, m), 7.66 (2H, m), 7.8
6 (2H, m), 8.58 (1H, m), 9.66 (1
H, s). Elemental analysis (C21H19NO2Calculated) (%): C, 79.47, H, 6.03; N,
4.41 Analytical value (%): C, 79.56; H, 6.02; N,
4.48 Reference Example 114'-hydroxybiphenyl-4-carboxylic acid 4-t-
Butylbenzylamide 4'-hydroxybiphenyl-4-carboxylic acid 0.8
g, 4-t-butylbenzylamine 0.61 g, 1-h
0.57 g of N,
To a solution of N-dimethylformamide (30 mL) was added hydrochloric acid 1-e.
Tyl-3- (3-dimethylaminopropyl) carbodii
0.71 g of amide was added and the mixture was heated and stirred at 90 ° C. for 3 hours. Anti
The reaction mixture was poured into ice water, extracted with ethyl acetate, and washed four times with water.
did. The obtained ethyl acetate solution is dried over anhydrous sodium sulfate.
After drying, the residue was dried under reduced pressure. The obtained residue is
Purification by muchromatography (eluent: chloroform: methanol
= 100: 1) and 4'-hydroxybiphenyl-4-
1.0 g of carboxylic acid 4-t-butylbenzylamide was obtained.
Was. The product obtained by partially recrystallizing from ethyl acetate
The following physical properties were shown. m. p. 180-181 ° C1 1 H NMR (DMSO-d6): Δ 1.26 (9
H, s), 4.44 (2H, d, J = 6.0 Hz),
6.87 (2H, m), 7.24 (2H, m), 7.3
5 (2H, m), 7.57 (2H, m), 7.68 (2
H, m), 7.93 (2H, m), 9.0 (1H,
m), 9.66 (1H, s). Elemental analysis (C24H25NO2Calculated) (%): C, 80.19; H, 7.01; N,
3.90 Analytical value (%): C, 80.22; H, 7.00; N,
3.91 Reference Example 124'-hydroxybiphenyl-4-carboxylic acid 4-t-
Butylphenylamide 4'-hydroxybiphenyl-4-carboxylic acid 2.0
g, 4-t-butylaniline 1.4 g, 1-hydroxy
Benzotriazole monohydrate 1.71 g of N, N-dimethyl
To a 20 mL solution of tilformamide was added 1-ethyl-3 hydrochloric acid.
-(3-dimethylaminopropyl) carbodiimide2.
15 g was added and the mixture was stirred at room temperature for 3 days. Ice the reaction mixture
, Extracted with ethyl acetate and washed four times with water. Got
After drying the ethyl acetate solution over anhydrous sodium sulfate, the pressure was reduced.
Dried down. The obtained residue is purified by medium pressure column chromatography.
(Eluent: hexane: ethyl acetate = 2: 1 to 1: 1)
And 4'-hydroxybiphenyl-4-carboxylic acid 4-
2.0 g of t-butylphenylamide was obtained.1 1 H NMR (DMSO-d6): Δ 1.29 (9
H, s), 6.89 (2H, m), 7.37 (2H,
m), 7.60 (2H, m), 7.73 (4H, m),
8.01 (2H, m), 9.69 (1H, s), 10.
18 (2H, s). Reference Example 134'-hydroxybiphenyl-4-carboxylic acid benzyl
Roxyamide 4'-hydroxybiphenyl-4-carboxylic acid 3.0
g, 1-hydroxybenzotriazole monohydrate 1.0
In 7 g of N, N-dimethylformamide 45 mL solution,
1-ethyl-3- (3-dimethylaminopropyl) hydrochloride
3.21 g of carbodiimide were added. In addition, benzene hydrochloride
2.46 g of ruoxyamine and 9 mL of triethylamine
The mixture was stirred overnight at room temperature. Pour the reaction mixture into ice water and add vinegar
The mixture was extracted with ethyl acetate and washed four times with water. Ethyl acetate obtained
The solution was dried over anhydrous magnesium sulfate and then dried under reduced pressure.
did. The residue obtained is washed with ether and 4'-hydro
Xybiphenyl-4-carboxylic acid benzyloxyamide
3.14 g were obtained.1 1 H NMR (DMSO-d6): δ 4.94 (2
H, s), 6.86 (2H, m), 7.3-7.5 (5
H, m), 7.56 (2H, m), 7.67 (2H,
m), 7.79 (2H, m), 9.64 (1H, b
r). Reference Example 14Benzyl 4'-benzyloxybiphenyl-4-cal
Boxylate 15 g of 4'-hydroxybiphenyl-4-carboxylic acid
18 mL of benzyl bromide in N, N-dimethylforma
To a 150 mL solution of amide, add 24 g of potassium carbonate and add room temperature
For 1 day. Pour the reaction mixture into 1 L of ice water and precipitate
The crystals obtained were collected by filtration. The obtained crystals are dissolved in chloroform.
Thaw, wash with water, dry over anhydrous sodium sulfate, and
To dryness. The residue obtained is washed with methanol and benzyl
4'-benzyloxybiphenyl-4-carboxyle
18.8 g were obtained.1 H NMR (CDCl3): Δ 5.13 (2H,
s), 5.39 (2H, s), 7.07 (2H, m),
7.2-7.7 (10H, m), 7.60 (4H,
m), 8.12 (2H, m). Reference Example 154'-benzyloxybiphenyl-4-carbonyl
Lorido Benzyl 4'-benzyloxybiphenyl-4-cal
18.8 g of boxylate (see Reference Example 14) in 20 m of water
L, dissolved in a mixed solution of 40 mL of dioxane,
Add 50 mL of aqueous sodium chloride solution and heat at 100 ° C overnight
Stirred. The reaction mixture was concentrated under reduced pressure, and the obtained residue was washed with water.
And adjusted to pH 3 with 1N hydrochloric acid.
The crystals were collected by filtration, washed with water, and washed with acetone to obtain 15 g of crude crystals.
To 2.58 g of the obtained crude crystals, 10 mL of thionyl chloride was added.
And heated under reflux for 2 hours. The reaction mixture was concentrated under reduced pressure.
Chloroform is added to the residue, and the precipitated crystals are collected by filtration.
4'-benzyloxybiphenyl-4-carbonyl
2.5 g of chloride were obtained.1 1 H NMR (DMSO-d6): Δ 5.15 (2
H, s), 7.10 (2H, m), 7.2-7.6 (5
H, m), 7.7-7.8 (4H, m), 7.96 (2
H, m). Reference Example 164'-benzyloxybiphenyl-4-carboxylic acid
Ndylmethylamide 4'-benzyloxybiphenyl-4-carbonyl
1 g of chloride (see Reference Example 15) and 0.1 g of triethylamine.
To a solution of 62 g of tetrahydrofuran in 30 mL, add N-methyl
Add 0.41 g of benzylamine and stir at room temperature overnight.
Was. The reaction mixture was poured into ice water and extracted with ethyl acetate.
After washing with 1N hydrochloric acid and washing with water, the obtained ethyl acetate solution was
After drying with sodium hydrogen sulfate, the mixture was dried under reduced pressure. Get
The residue was purified by medium pressure column chromatography (eluent: chloro
Form) and 4'-benzyloxybiphenyl-4-ca
0.95 g of benzyl benzyl methylamide was obtained.1 1 H NMR (DMSO-d6): Δ 2.8-3.2
(3H, m), 4.5-4.9 (2H, m), 5.13
(2H, s), 7.07 (2H, m), 7.1-7.7
(16H, m). Reference Example 174'-hydroxybiphenyl-4-carboxylic acid benzyl
Rumethylamide 4'-benzyloxybiphenyl-4-carboxylic acid
0.45 g of benzylmethylamide (see Reference Example 16)
Dissolve in a mixed solution of 50 mL of ethanol and 50 mL of dioxane
Dissolve and 10% palladium on carbon (50% water-containing) 150mg
And catalytically reduced at normal pressure overnight. Filter the reaction mixture
And concentrated under reduced pressure to give 4'-hydroxybiphenyl-4-.
0.41 g of carboxylic acid benzylmethylamide was obtained.1 H NMR (CDCl3): Δ2.8-3.2 (3
H, m), 4.5-4.9 (2H, m), 6.85 (2
H, m), 7.1-7.7 (12H, m). Reference Example 184'-benzyloxybiphenyl-4-carboxylic acid
(4-t-butylbenzyl) methylamide 4'-benzyloxybiphenyl-4-carbonyl
1.2 g of chloride (see Reference Example 15), triethylamine
0.41 g of a 30 mL solution of tetrahydrofuran was added with (4
-Tert-butylbenzyl) methylamine 0.72 g of tet
A 10 mL solution of lahydrofuran was added dropwise and stirred at room temperature for 3 hours.
Stirred. Pour the reaction mixture into ice water and extract with ethyl acetate.
Was. After washing with 1N hydrochloric acid, the obtained ethyl acetate solution was dried.
After drying over sodium sulfate, it was evaporated to dryness under reduced pressure. Obtained
The residue was purified by medium pressure column chromatography (eluent: chloropho
Lum) and 4'-benzyloxybiphenyl-4-cal
Boronic acid (4-t-butylbenzyl) methylamide
2 g were obtained.1 H NMR (CDCl3): Δ 1.34 (9H,
s), 2.8-3.2 (3H, m), 4.4-4.8.
(2H, m), 5.12 (2H, s), 7.05 (2
H, m), 7.1-7.6 (15H, m). Reference Example 194′-hydroxybiphenyl-4-carboxylic acid (4-
t-butylbenzyl) methylamide 4'-benzyloxybiphenyl-4-carboxylic acid
(4-t-butylbenzyl) methylamide (Reference Example 18
0.6 g of methanol 50 mL, dioxane 50
dissolved in 10 mL palladium on carbon
mg, and the mixture was catalytically reduced at normal pressure for 5 hours. Reaction mixture
And concentrated under reduced pressure to give 4'-hydroxybiphenyl.
-4-Carboxylic acid (4-t-butylbenzyl) methyl
0.45 g of the amide was obtained.1 1 H NMR (DMSO-d6): Δ 1.32 (9
H, s), 2.8-3.2 (3H, m), 4.4-4.
8 (2H, m), 6.82 (2H, m), 7.0-7.
4 (3H, m), 7.38 (4H, m), 7.48 (4
H, m). Reference Example 204'-benzyloxybiphenyl-4-carboxylic acid
N-butyramide 4'-benzyloxybiphenyl-4-carbonyl
1 g of chloride (see Reference Example 15) and 0.1 g of triethylamine.
To a suspension of 62 g of tetrahydrofuran in 30 mL was added N-
Add 0.56 g of butylbenzylamine and stir at room temperature for 2 hours.
Stirred. Pour the reaction mixture into ice water and extract with ethyl acetate.
Was. After washing with 1N hydrochloric acid and washing with water, the obtained ethyl acetate solution
Was dried over anhydrous sodium sulfate and then dried under reduced pressure.
The resulting residue is purified by medium pressure column chromatography (eluent:
Roloform) and 4'-benzyloxybiphenyl-4
-1.02 g of carboxylic acid benzylbutyramide was obtained.
Was.1 H NMR (CDCl3): Δ 0.6-1.8 (7
H, m), 3.1-3.6 (2H, m), 4.5-4.
9 (2H, m), 5.14 (2H, s), 7.07 (2
H, m), 7.1-7.7 (16H, m). Reference Example 214'-hydroxybiphenyl-4-carboxylic acid benzyl
Rubutylamide 4'-benzyloxybiphenyl-4-carboxylic acid
0.6 g of benzylbutyramide (see Reference Example 20)
Dissolved in a mixed solution of 30 mL of phenol and 30 mL of dioxane
And add 0.15 g of 10% palladium on carbon,
The reaction was reduced overnight. The reaction mixture was filtered and concentrated under reduced pressure.
And 4'-hydroxybiphenyl-4-carboxylic acid
0.5 g of benzylbutyramide was obtained.1 1 H NMR (DMSO-d6): Δ 0.6-1.7
(7H, m), 3.22 (2H, m), 4.4-4.8
(2H, m), 6.85 (2H, m), 7.1-7.5
(7H, m), 7.53 (2H, m), 7.64 (2
H, m), 9.61 (1H, s). Reference Example 224'-hydroxybiphenyl-4-carboxylic acid 4-t-
Butylbenzyloctylamide 4'-hydroxybiphenyl-4-carboxylic acid 1.5
g, 4-t-butylbenzyloctylamine, 1.9 g,
1.07 g of 1-hydroxybenzotriazole monohydrate
To a solution of N, N-dimethylformamide in 20 mL
1-ethyl-3- (3-dimethylaminopropyl) cal
Add 1.34 g of bodimide and heat and stir at 60 ° C overnight.
Was. The reaction mixture was poured into ice water, extracted with ethyl acetate,
Washed twice. The obtained ethyl acetate solution is dried over anhydrous sodium sulfate.
And dried under reduced pressure. The resulting residue is medium
Purification by pressure column chromatography (eluent: chloroform: meta)
Nol = 100: 1) and 4'-hydroxybiphenyl
4-Carboxylic acid 4-t-butylbenzyloctylamido
0.47 g was obtained.1 1 H NMR (DMSO-d6): Δ 0.6-1.7
(24H, m), 3.0-3.4 (2H, m), 4.4
-4.8 (2H, m), 6.85 (2H, m), 7.0
-7.5 (6H, m), 7.52 (2H, m), 7.6
3 (2H, m), 9.63 (1H, s). Reference Example 234 '-[2- (4-t-butylphenyl) -1RS-H
Droxy-1-methylethyl] -biphenyl-4-o
Le Magnesium 0.68mg suspension in ether 30mL
7.2 g of 4-t-butylbenzyl bromide in ether
10 ml of the solution was added dropwise, and at room temperature for 30 minutes under an argon atmosphere
While stirring. Further, ice-cooled 1- (4'-hydroxybiphenyl)
2.1 g of tetrahydrofura
100 ml solution was added dropwise and stirred for 2 hours. Reaction mixing
Diluted with aqueous ammonium chloride solution and extracted with ethyl acetate.
Exited and washed twice with water. The obtained ethyl acetate solution is subjected to sulfuric anhydride.
After drying over magnesium, the mixture was evaporated to dryness under reduced pressure.
The residue is washed with hexane, recrystallized from methanol,
4 '-[2- (4-t-butylphenyl) -1RS-h
Droxy-1-methylethyl] -biphenyl-4-o
1.7 g of crystallized crystals were obtained. m. p. Decomposes around 158 ° C1 1 H NMR (DMSO-d6): Δ 1.23 (9
H, s), 1.35 (3H, s), 2.92 (2H,
s), 4.99 (1H, s), 6.83 (2H, m),
7.02 (2H, m), 7.19 (2H, m), 7.4
7 (6H, m), 9.51 (1H, s). Elemental analysis (C25H28O2Calculated value (%): C, 83.29; H, 7.83 Analytical value (%): C, 82.87; H, 7.99
フロントページの続き Fターム(参考) 4C206 AA02 AA03 CA12 JA11 NA14 ZA81 ZC11 4H006 AA01 AB20 AB27 AB28 Continuation of the front page F term (reference) 4C206 AA02 AA03 CA12 JA11 NA14 ZA81 ZC11 4H006 AA01 AB20 AB27 AB28
Claims (3)
R1OCH2C6H5、−COR2または−C(OH)
R1R2を表し、R1は、水素原子または置換基を有す
ることもあるアルキル基を表し、R2は、置換基を有す
ることもあるアルキル基を表す。)で示されるビフェニ
ル誘導体。1. A compound represented by the following formula (I): (Wherein R is -COOH, -CONR 1 R 2 , -CON
R 1 OCH 2 C 6 H 5 , —COR 2 or —C (OH)
R 1 represents R 2 , R 1 represents a hydrogen atom or an alkyl group which may have a substituent, and R 2 represents an alkyl group which may have a substituent. ).
である請求項1に記載のビフェニル誘導体。2. R is -CONR 1 R 2 or -COR 2
The biphenyl derivative according to claim 1, which is
請求項2に記載のビフェニル誘導体。3. The biphenyl derivative according to claim 2, wherein R 2 is a 4-t-butylbenzyl group.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000245314A JP2002020362A (en) | 2000-07-06 | 2000-07-06 | New biphenyl derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000245314A JP2002020362A (en) | 2000-07-06 | 2000-07-06 | New biphenyl derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2002020362A true JP2002020362A (en) | 2002-01-23 |
Family
ID=18735862
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000245314A Pending JP2002020362A (en) | 2000-07-06 | 2000-07-06 | New biphenyl derivative |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2002020362A (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004083167A1 (en) * | 2003-03-18 | 2004-09-30 | Sankyo Company Limited | Sulfamide derivative and medicinal composition thereof |
JP2008525530A (en) * | 2004-12-28 | 2008-07-17 | キネックス ファーマシューティカルズ, エルエルシー | Compositions and methods for treating cell proliferative disorders |
US8236799B2 (en) | 2004-12-28 | 2012-08-07 | Kinex Pharmaceuticals, Llc | Biaryl compositions and methods for modulating a kinase cascade |
US8293739B2 (en) | 2006-12-28 | 2012-10-23 | Kinex Pharmaceuticals, Llc | Process for the preparation of compositions for modulating a kinase cascade and methods of use thereof |
US8309549B2 (en) | 2006-12-28 | 2012-11-13 | Kinex Pharmaceuticals, Llc | Compositions for modulating a kinase cascade and methods of use thereof |
US8748423B2 (en) | 2010-04-16 | 2014-06-10 | Kinex Pharmaceuticals, Llc | Compositions and methods for the prevention and treatment of cancer |
US9926273B2 (en) | 2012-08-30 | 2018-03-27 | Athenex, Inc. | Composition and methods for modulating a kinase cascade |
US10196357B2 (en) | 2007-04-13 | 2019-02-05 | Athenex, Inc. | Biaryl compositions and methods for modulating a kinase cascade |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11510813A (en) * | 1995-08-16 | 1999-09-21 | ドゥーケーン ユニバーシティ オブ ザ ホーリー ゴースト | Non-steroidal sulfatase inhibitor compound and method for producing the same |
JP2002511459A (en) * | 1998-04-09 | 2002-04-16 | ノバルティス アクチエンゲゼルシャフト | Chromanone and thiochromanone derivatives |
JP2002525322A (en) * | 1998-10-01 | 2002-08-13 | ドゥーケーン ユニバーシティ オブ ザ ホーリー ゴースト | Compound for treating estrogen-dependent disease, and method for producing and using the compound |
JP2002293768A (en) * | 1999-07-06 | 2002-10-09 | Teikoku Hormone Mfg Co Ltd | Phenyl sulfamate derivative |
-
2000
- 2000-07-06 JP JP2000245314A patent/JP2002020362A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11510813A (en) * | 1995-08-16 | 1999-09-21 | ドゥーケーン ユニバーシティ オブ ザ ホーリー ゴースト | Non-steroidal sulfatase inhibitor compound and method for producing the same |
JP2002511459A (en) * | 1998-04-09 | 2002-04-16 | ノバルティス アクチエンゲゼルシャフト | Chromanone and thiochromanone derivatives |
JP2002525322A (en) * | 1998-10-01 | 2002-08-13 | ドゥーケーン ユニバーシティ オブ ザ ホーリー ゴースト | Compound for treating estrogen-dependent disease, and method for producing and using the compound |
JP2002293768A (en) * | 1999-07-06 | 2002-10-09 | Teikoku Hormone Mfg Co Ltd | Phenyl sulfamate derivative |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004083167A1 (en) * | 2003-03-18 | 2004-09-30 | Sankyo Company Limited | Sulfamide derivative and medicinal composition thereof |
US8980890B2 (en) | 2004-12-28 | 2015-03-17 | Kinex Pharmaceuticals, Llc | Compositions and methods of treating cell proliferation disorders |
JP2008525530A (en) * | 2004-12-28 | 2008-07-17 | キネックス ファーマシューティカルズ, エルエルシー | Compositions and methods for treating cell proliferative disorders |
US8236799B2 (en) | 2004-12-28 | 2012-08-07 | Kinex Pharmaceuticals, Llc | Biaryl compositions and methods for modulating a kinase cascade |
US9655903B2 (en) | 2004-12-28 | 2017-05-23 | Athenex, Inc. | Compositions and methods of treating cell proliferation disorders |
US8598169B2 (en) | 2004-12-28 | 2013-12-03 | Kinex Pharmaceuticals, Llc | Biaryl compositions and methods for modulating a kinase cascade |
US9580387B2 (en) | 2004-12-28 | 2017-02-28 | Athenex, Inc. | Biaryl compositions and methods for modulating a kinase cascade |
US8309549B2 (en) | 2006-12-28 | 2012-11-13 | Kinex Pharmaceuticals, Llc | Compositions for modulating a kinase cascade and methods of use thereof |
US8901297B2 (en) | 2006-12-28 | 2014-12-02 | Kinex Pharmaceuticals, Llc | Compositions for modulating a kinase cascade and methods of use thereof |
US9556120B2 (en) | 2006-12-28 | 2017-01-31 | Athenex, Inc. | Compositions for modulating a kinase cascade and methods of use thereof |
US8293739B2 (en) | 2006-12-28 | 2012-10-23 | Kinex Pharmaceuticals, Llc | Process for the preparation of compositions for modulating a kinase cascade and methods of use thereof |
US10323001B2 (en) | 2006-12-28 | 2019-06-18 | Athenex, Inc. | Compositions for modulating a kinase cascade and methods of use thereof |
US10196357B2 (en) | 2007-04-13 | 2019-02-05 | Athenex, Inc. | Biaryl compositions and methods for modulating a kinase cascade |
US8748423B2 (en) | 2010-04-16 | 2014-06-10 | Kinex Pharmaceuticals, Llc | Compositions and methods for the prevention and treatment of cancer |
US9926273B2 (en) | 2012-08-30 | 2018-03-27 | Athenex, Inc. | Composition and methods for modulating a kinase cascade |
US10106505B2 (en) | 2012-08-30 | 2018-10-23 | Athenex, Inc. | Composition and methods for modulating a kinase cascade |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102906087B (en) | Prepare the method for chiral triazole ketone | |
DE60221391T2 (en) | SUBSTITUTED INDOLESE DERIVATIVES AS INHIBITORS OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) | |
IL147012A (en) | Indole derivatives, pharmaceutical compositions comprising them and use thereof for the manufacture of a medicament for the treatment of diseases associated with over activity of osteoclasts | |
JPH04134077A (en) | Isoxazole compounds | |
JP2002020362A (en) | New biphenyl derivative | |
PT1828172E (en) | Pyrrole derivatives having crth2 receptor antagonist activity | |
US4438126A (en) | Lower alkanoic acid derivatives of 2-oxo-benzoxazolines and aldose reductase inhibiting compositions thereof | |
JPH06135948A (en) | Styrene derivative or its salt | |
JPS6277380A (en) | Method for producing heterocyclic compounds | |
EP1268422A1 (en) | Indoles for treating diseases that can be treated using thyroid hormones | |
JP2973143B2 (en) | Process for producing 3-acylamino-6-phenyloxy-7-alkylsulfonylamino-4H-1-benzopyran-4-one or a salt thereof | |
JPH05286962A (en) | 5-aminoflavone derivative | |
US5446065A (en) | Sulfonamides of phenylalkylamines or phenoxyalkylamines processes for their preparation and medicaments containing these compounds | |
WO1992002500A1 (en) | 2-phenylindole derivative | |
JPH07267961A (en) | Benzofuro [3,2-d pyrimidin-4-one derivative | |
JP3183724B2 (en) | Amidinocyclohexane derivative | |
US5922747A (en) | Indole derivatives as steroid 5α-reductase inhibitors | |
US5624948A (en) | 1-(2-benzimidazolyl)-1,5-diazacyclooctane compounds | |
JP4199539B2 (en) | N- (4-aryloxypiperidin-1-ylalkyl) cinnamic amides as CCR-3 receptor antagonists | |
CN104892640B (en) | Simultaneously [3,2 b] [1,2,4] triazole derivative and the application of the benzoyl thiazole of 2 phenyl 6 | |
DE60021859T2 (en) | 1, 2, 3, 4-TETRAHYDRO-1-NAPHTHALENAMINE COMPOUNDS FOR THERAPEUTIC USE | |
NO312549B1 (en) | New Process for Preparation of (-) - Trans-N-p-Fluorobenzoylmethyl-4- (p-fluorophenyl) -3 - [[3,4- (methylenedioxy) phenoxy] methyl] -piperidine | |
JP3760484B2 (en) | Thieno [2,3-d] pyrimidin-4-one derivatives | |
Hjeds et al. | Muscimol analogues. Synthesis of isomuscimol (3-amino-methyl-5-isoxazolol) and some derivatives of azamuscimol (5-aminomethyl-3-pyrazolol) | |
JPH083132A (en) | Prolylproline derivative and its new production |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070612 |
|
RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20080507 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20091215 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20100420 |